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INVESTIGATING MECHANISMS IN NOCICEPTORS DRIVING 
ONGOING ACTIVITY AND ONGOING PAIN 
 
Elia R. Lopez, M.S. 
Advisory Professor: Edgar T. Walters, PhD 
Co-Advisory Professor: Carmen W. Dessauer, PhD 
 
Ongoing (apparently spontaneous) pain at rest is a major complaint of patients 
suffering from many forms of acute and chronic pain, including acute and persistent 
postsurgical pain. Accumulating evidence suggests ongoing activity in nociceptors is a 
major driver of ongoing pain. Ongoing activity can be generated in sensory neurons in 
the absence of sensory generator potentials if one or more of three neurophysiological 
alterations occur – prolonged depolarization of resting membrane potential (RMP), 
hyperpolarization of action potential (AP) threshold, and/or increased amplitude of 
depolarizing spontaneous fluctuations of membrane potential (DSFs) to bridge the gap 
between RMP and AP threshold. Cellular signaling pathways that increase DSF 
amplitude and promote ongoing activity acutely in nociceptors were unknown for any 
neuromodulator, as were the neurophysiological alterations that underly ongoing activity 
in nociceptors after deep tissue incision. The work presented in this dissertation sought 
to identify a cellular signaling pathway and injury- and inflammation-related 
neuromodulator that induces alterations that drive hyperexcitability, such as enhanced 
DSFs, and thereby potentiates ongoing activity in nociceptors, as well as to determine 
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the alterations that contribute to nociceptor hyperactivity associated with postsurgical 
pain. 
A combination of whole-cell patch clamp electrophysiology, pharmacology, and 
high content microscopy was used to define the effects of low concentrations of the 
injury-related proinflammatory mediator serotonin and the major pathway by which it 
exerts its effects. This study shows that serotonin enhances DSFs, hyperpolarizes AP 
threshold, and thereby potentiates OA in isolated rat DRG neurons at a concentration 
of 100 nM, and serotonin exerts these effects on nonpeptidergic nociceptors via the 5-
HT4 receptor and downstream cAMP signaling via PKA and EPAC. Furthermore, whole-
cell patch clamp recordings of primary DRG neurons, analysis of spontaneous pain 
behavior, and RNA sequencing were used to reveal an unexpected persistence of 
hyperexcitability in isolated DRG neurons and potentially associated differential gene 
expression, both of which were found after the behavioral expression of postsurgical 
pain had resolved. In addition to elucidating cell signaling mechanisms that can 
contribute to acute ongoing activity in nociceptors, these studies set the stage for future 
investigations addressing important questions about nociceptor contributions to pain.   
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 Pain is defined by the International Association for the Study of Pain as “an 
unpleasant sensory and emotional experience associated with, or resembling that 
associated with, actual or potential tissue damage.” Pain, while unpleasant at the least 
and unbearable at the worst, is integral to survival. Pain tells us to remove ourselves 
from something or stop engaging in an activity that will cause harm. It is also pain that 
lets us know to protect ourselves when we are vulnerable while a wound or infection is 
healing. People with gene mutations that cause congenital insensitivity to pain often 
accumulate injuries that may go undetected and can ultimately lead to reduced life 
expectancy (Daneshjou et al., 2012; Mifsud et al., 2019; van den Bosch et al., 2014). 
Sensitivity to pain can help us live long and healthy lives. However, pain can become 
pathological; when pain is no longer alerting us to actual or potential injury but becomes 
persistent, it can exact a heavy toll on an individual and on society. Chronic pain is 
experienced by at least 11% of adults in the United States and is one of the most 
common reasons adults seek medical care (Dahlhamer et al., 2018). Ongoing 
spontaneous pain is often the worst complaint of patients suffering from many forms of 
pain (Backonja and Stacey, 2004; Bennett, 2012). Importantly, severe and persistent 
pain can tremendously impair quality of life, and current treatment options are often 
inadequate. Thus, it is important to better understand the mechanisms that drive pain 
and how it becomes pathological. 
1.1. The physiology and pathophysiology of pain: an overview of the 
alterations that underly acute and chronic pain  
 Pain and other sensory information is transduced by primary afferents (sensory 
neurons). Different classes of sensory neurons are specialized to respond to different 
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types of stimuli. Low threshold mechanoreceptor neurons (LTMRs) are mostly made up 
of large myelinated Aβ-fibers and some of the smaller myelinated Aδ-fibers. Many of 
these fast-conducting neurons respond to innocuous mechanical stimuli, such as light 
touch. Nociceptors, sensory neurons specialized for the detection of injury and 
inflammation (Basbaum et al., 2009; Das, 2015; Dubin and Patapoutian, 2010), mostly 
have unmyelinated, small-diameter C-fibers exhibiting low conduction velocity. These 
respond to noxious mechanical, heat, cold, and/or chemical stimuli. Many Aδ neurons 
and a small subset of Aβ neurons are also nociceptors. 
 Under normal conditions tissue damage activates peripheral terminals of 
nociceptors. This initiates electrical signals, action potentials (APs), that travel along the 
axons of the nociceptors to the spinal cord, where they synapse with second-order 
interneurons in the dorsal horn of the spinal cord. The electrical signal is relayed to 
second-order neurons by synaptic release of the neurotransmitter glutamate and one or 
more neuropeptides, including substance P and calcitonin gene-related peptide (CGRP) 
(D’Mello and Dickenson, 2008; Yam et al., 2018). This signal excites second-order 
neurons, generating APs that travel along their axons, many of which cross over the 
spinal cord to the spinothalamic tract, then traveling up to the thalamus of the brain. 
Thalamic third-order neurons then relay the signal to the region of the somatosensory 
cortex which maps onto the region of the body where the signal originated, as well as to 
other brain regions such as the insula and anterior cingulate cortex (Bushnell and 
Apkarian, 2005). This results in the conscious perception of pain in the injured area. 
Additionally, there are descending pathways that enhance or suppress synaptic 
transmission in the ascending pain pathways (Ren and Dubner, 2008), but the focus 
here will be on the primary sensory neurons that initiate activity in the pain pathways. 
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 Activation of nociceptors, which normally are electrically silent, produces 
immediate pain and protective reflexive responses. It also produces sensitization of 
neural and behavioral responses to subsequent noxious and innocuous stimuli. These 
sensitizing effects are mediated by alterations in pain pathways. One sensitizing effect 
is enhanced responsiveness of primary sensory neurons to stimulation of their receptive 
fields (peripheral sensitization). Another is enhanced responsiveness at the level of the 
spinal cord and brain to sensory input from the periphery (central sensitization) 
(Meacham et al., 2017). At the peripheral terminals, enhanced sensory generator 
potentials and reduced AP threshold lead to increases in nociceptor discharge and input 
to the central nervous system (CNS). If injury or infection is severe enough to damage 
peripheral nerves, ectopic generation of APs can occur in the axons (often at neuromas) 
or the cell bodies of sensory neurons (Walters, 2019), which are clustered in the dorsal 
root ganglia (DRG) or trigeminal ganglia.  
 Increased nociceptor activity can produce synaptic plasticity (Price and Inyang, 
2015; Reichling and Levine, 2009), including long-term synaptic potentiation (LTP) and 
heterosynaptic facilitation (Klein et al., 2008; Pace et al., 2018), which amplifies signals 
in the pain pathways and contributes to central sensitization. A reduction in inhibitory 
tone at the presynaptic terminals of nociceptors may also accompany enhanced activity 
(Comitato and Bardoni, 2021; Gradwell et al., 2020; Guo and Hu, 2014; Hughes and 
Todd, 2020). In the brain, cortical remodeling can contribute to augmented pain 
perception (Puntillo et al., 2021). Furthermore, increased facilitation and decreased 
inhibition by descending modulatory pathways can further enhance transmission of 
nociceptive information at the level of the spinal cord (Ossipov et al., 2014). 
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 Reduced threshold and subsequent enhanced responsiveness of nociceptors to 
stimulation underlies hyperalgesia, an increased sensation of pain from a stimulus that 
normally provokes pain. In addition, central sensitization allows for activity in LTMRs to 
activate pain pathways, resulting in allodynia, sensation of pain in response to normally 
innocuous stimuli. In addition to hyperalgesia and allodynia, ongoing (apparently 
spontaneous) pain at rest is a major complaint of patients suffering from many forms of 
acute and chronic pain. Accumulating evidence links ongoing pain with ongoing activity 
(OA, also known as spontaneous activity) that may occur in sensory neurons and their 
downstream targets in the spinal dorsal horn in the absence of an apparent stimulus. 
The findings that activation of even a few human nociceptors in vivo evokes immediate 
pain (Nagi et al., 2019; Ochoa and Torebjörk, 1989) and the high incidence of OA in C-
fiber nociceptors in microneurographic recordings from patients with ongoing 
neuropathic pain (Kleggetveit et al., 2012; Serra et al., 2012) indicate that a major driver 
of ongoing human pain is OA in nociceptors. 
1.2. Observing drivers of pain in isolated rodent DRG neurons 
 The OA observed in vivo, can be retained in nociceptor somata dissociated from 
excised DRG. Electrophysiological recordings from single DRG neurons dissociated 
from human patients (North et al., 2019) and recordings from rodent nociceptors in 
preclinical neuropathic, inflammatory, and incisional pain models (Bedi et al., 2010; 
Djouhri et al., 2006; North et al., 2019; Xu and Brennan, 2010) demonstrate an increased 
incidence of OA in DRG neurons linked to ongoing pain. The occurrence of pain-related 
OA in dissociated nociceptors in vitro that is similar in pattern and incidence to that 
occurring in vivo during persistent neuropathic pain (Bedi et al., 2010) provides a special 
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opportunity to define the cellular mechanisms in nociceptors that enable their ongoing 
and spontaneous activity. 
 Examination of OA in isolated DRG neurons has allowed us to make great strides 
in our understanding of the electrophysiological alterations that drive a sensory neuron 
from a silent state to a state of OA. As illustrated by our findings in a model of 
neuropathic pain (Odem et al., 2018), three basic neurophysiological alterations can 
generate OA in nociceptors in the absence of sensory generator potentials – prolonged 
depolarization of the resting membrane potential (RMP), hyperpolarization of the action 
potential (AP) threshold, and an increase in the incidence of large depolarizing 
spontaneous fluctuations (DSFs) of membrane potential that can intermittently bridge 
the gap between RMP and AP threshold (Figure 1). While alterations in RMP and AP 
threshold are commonly recognized contributors to neuronal excitability, the importance 
of DSFs has only recently been recognized. Large DSFs are prominent in neurons with 
OA, and they play a major role in controlling the low firing rate and irregular pattern of 
OA observed in DRG neurons dissociated in animal models of persistent pain, including 
chronic constriction injury of the sciatic nerve (Study and Kral, 1996), spinal cord injury 
(Berkey et al., 2020; Odem et al., 2018), and treatment with the chemotherapeutic 
cisplatin (Laumet et al., 2020), as well as in DRG neurons taken from humans with 





 As described above, DRG neurons are a diverse population of sensory neurons 
that are specialized for different sensory modalities. Cutaneous LTMRs sense non-
noxious mechanical force; cold receptors respond to cold; and overlapping subsets of 
nociceptors respond to noxious mechanical force, noxious heat, and noxious chemicals. 
DRG neurons can be classified based on a variety of molecular markers, cellular 
properties, and gene expression profiles. LTMRs are relatively large in size compared 
to nociceptors and express Tropomyosin receptor kinase B (TrkB, a receptor for brain-
derived neurotrophic factor [BDNF]) or TrkC (a receptor for neurotrophin-3 [NT-3]). Cold 
Figure 1. Summary of neurophysiological specializations that promote OA in 
nociceptors. Representative traces from naïve rats (normal state) and rats with 
spinal cord injury (OA state). AP, action potential; DSF, depolarizing spontaneous 
fluctuation; MP, membrane potential; OA, ongoing activity; RMP, resting membrane 
potential. Reprinted from Title: Isolated nociceptors reveal multiple specializations for 
generating irregular ongoing activity associated with ongoing pain; Authors: Max A. 
Odem, Alexis G. Bavencoffe, Ryan M. Cassidy, Elia R. Lopez, Jinbin Tian, Carmen 
W. Dessauer, and Edgar T. Walters; Publication: Pain; Publisher: Wolters Kluwer 
Health, Inc.; Date: July 12, 2018. Use of the text and figures are granted for use in a 
dissertation by an author without formal licensing from Wolters Kluwer Health, Inc. 
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receptors have small somata, express transient receptor potential melastatin 8 
(TRPM8), and do not express CGRP or bind isolectin B4 (IB4) (Dhaka et al., 2008; Peier 
et al., 2002; Takashima et al., 2007). Nociceptors are a diverse group with mostly small 
to medium soma sizes. One common way to classify nociceptors is by expression of 
CGRP (marking “peptidergic” nociceptors) or binding of IB4 (marking “non-peptidergic” 
nociceptors), as CGRP and IB4 binding distinguish largely separate populations in mice 
with only a relatively small subset of nociceptors positive for both. A larger overlap 
between CGRP-expressing and IB4-binding DRG neurons is observed in rats (Price and 
Flores, 2007). In mice, all peptidergic nociceptors express transient receptor potential 
vanilloid 1 (TRPV1), while a subset of non-peptidergic nociceptors express this channel, 
which is well known for its involvement in detection of heat and pain, especially in 
response to capsaicin, the component of chili peppers that causes a burning sensation. 
Recent findings in human DRG neurons show substantial differences from mice in the 
expression of these nociceptive markers (Shiers et al., 2020). 
1.3. Injury- and inflammatory-related signals sensitize neurons 
 While it is usually nociceptive neurons that transduce the signals that lead to the 
sensation of pain, the transduction, transmission, and perception of pain are modified 
and often initiated by modulators released from non-neuronal cells. The peripheral 
terminals of nociceptors are packed with receptors and ion channels that detect 
molecular mediators released from immune cells and other cell types during injury and 
inflammation. During neuroinflammation, glial cells are activated and release pro-
inflammatory cytokines and chemokines that contribute to peripheral and central 
sensitization. Neurons themselves can also release neuropeptides and other signals 
that influence inflammatory cells, leading to neurogenic inflammation.  
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1.3.1. Neuroimmune interactions 
 In response to injury, immune cells release a variety of inflammatory mediators 
that activate and/or sensitize nociceptors (Figure 2). Mast cells are tissue-resident 
immune cells found near externally exposed surfaces that act as “first responders” to 
foreign invaders and tissue damage. Mast cells are known to associate closely with 
nociceptors and to contribute to the pathobiology of several types of pain, including 
chemotherapy-induced peripheral neuropathy (CIPN), pelvic pain, and osteoarthritis 
(Azimi et al., 2016; Breser et al., 2017; Forsythe and Bienenstock, 2012; Gupta and 
Harvima, 2018; Jaggi et al., 2017; Sousa-Valente et al., 2018). Upon activation, mast 
cells immediately release preformed granules containing nociceptor-sensitizing 
mediators, including serotonin (which is of particular interest and will be introduced in 
detail in Chapter 3), histamine, cytokines (e.g. Interleukin 5 [IL-5], tumor necrosis factor 
alpha [TNF-], IL-1, IL-6, and IL-17), and tryptase. Later, via de novo synthesis, mast 
cells release cytokines, growth factors (e.g. nerve growth factor), and neuropeptides 
(e.g. substance P). Meanwhile, macrophages and neutrophils are activated at and 
mobilized to the site of injury where they also release a host of inflammatory cytokines, 
growth factors, and lipids (e.g., IL-1, IL-6, and prostaglandin E2 [PGE2]) that can 
activate and sensitize nociceptors to increase pain. It was demonstrated recently that 
angiotensin receptor 2-expressing macrophages at the site of nerve injury are a critical 





 In addition to their roles in nociceptor activation and sensitization at sites of injury, 
neuroimmune interactions are also known to take place in the DRG where immune cells 
interact with nociceptor somata to modulate pain. Mast cell activation in the DRG 
contributes to pain in rodent models of sickle cell disease, sciatic nerve injury, and CIPN 
(Gao et al., 2016; Saleem et al., 2019; Vincent et al., 2013). Macrophages, monocytes 
Figure 2. Immune cells release mediators that produce peripheral sensitization 
of nociceptor sensory neurons and pain. During inflammation, tissue-resident and 
recruited immune cells secrete molecular mediators that act on the peripheral 
nerve terminals of nociceptor neurons to produce pain sensitization. In these 
neurons, specific cytokine, lipid, and growth factor receptor intracellular signaling 
pathways lead to phosphorylation and/or gating of ion channels Nav1.7, Nav1.8, 
Nav1.9, TRPV1, and TRPA1, leading to increased action potential generation 
and pain sensitivity. Reprinted with permission under license. Title: Nociceptor 
Sensory Neuron–Immune Interactions in Pain and Inflammation; Authors: Felipe A. 
Pinho-Ribeiro, Waldiceu A. Verri, and Isaac M. Chiu; Publication: Trends in 




and neutrophils increase in the DRG in rodent models of radiculopathy, systemic 
inflammation, CIPN and peripheral nerve injury (Kim and Moalem-Taylor, 2011; Liu et 
al., 2014; Yoon et al., 2012; Zhang et al., 2016, 2021), and expansion and proliferation 
of the macrophage populations near the somata of injured sensory neurons makes a 
critical contribution to the initiation and maintenance of neuropathic pain in a mouse 
spared nerve injury model (Yu et al., 2020). 
 Furthermore, mast cells, macrophages, neutrophils, and T cells express 
receptors for neurotransmitters and neuropeptides, such as vasoactive intestinal 
peptide, CGRP, and substance P, released from nociceptors during neurogenic 
inflammation and thus can respond directly to nociceptor activity. Neuropeptides 
potentiate activation of mast cells (Aich et al., 2015; Kim et al., 2014; Rosa and Fantozzi, 
2013). Thus, a feedback mechanism in which mast cell activation in response to tissue 
damage leads to excitation of nociceptors, which in turn release neuropeptides that 
cause further activation of mast cells can sustain activity in pain pathways. This cycle of 
mast cell activation and peripheral nerve sensitization may play a role in the 
development and maintenance of chronic pain (Austin and Moalem-Taylor, 2010). 
Similarly, substance P induces the release of pro-inflammatory cytokines from 
macrophages and monocytes (Lotz et al., 1988; Sun et al., 2008). 
1.3.2. Neuroglial interactions 
 In the move away from a neurocentric view of pain, another cell type that has 
come into focus as intimately coupled to neurons in pain sensitization is glial cells. 
Neuroglia include Schwann cells and satellite glial cells (SGCs) in the peripheral 
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nervous system (PNS) and microglia, astrocytes, and oligodendrocytes in the CNS. The 
focus here is on glial effects on nociceptors.  
 Schwann cells interact with sensory nerve fibers and under physiological 
conditions maintain the local environment, help form the myelin sheath around 
myelinated axons, and envelop bundles of unmyelinated C-fibers (Kidd et al., 2013). 
However, nerve injury triggers a phenotypic switch in Schwann cells, causing them to 
proliferate, migrate, and secrete factors that cause nerve degeneration, regeneration, 
and inflammation (Jessen and Mirsky, 2019). Secreted factors include the pro-
inflammatory mediators TNF-α, IL-1, IL-6, and PGE2 (Bolin et al., 1995; Muja and 
DeVries, 2004; Murwani et al., 1996; Shamash et al., 2002).  
 Satellite glial cells (SGCs) envelop neuronal somata in the DRG. SGCs couple 
to each other via gap junctions, and there is evidence suggesting they can synchronize 
the activity of sensory neurons (Spray et al., 2019). Noxious stimulation or injury of 
sensory neurons leads to increased gap junction coupling between SGCs and their 
release of proinflammatory mediators. This leads to increased activity of the sensory 
neurons and promotes infiltration of immune cells. For example, cisplatin effects on 
SGCs lead to increased release of TNF-α and IL-6, leading to increased excitability of 
sensory neurons (Leo et al., 2021).   
 Sensitized sensory neurons also release colony stimulating factor 1 (CSF1) in 
the spinal cord, which induces proliferation and activation of microglia (Guan et al., 
2016), a specialized population of macrophages that function as glial cells in the CNS. 
Activated microglia in turn elicit activation and proliferation of astrocytes. These 
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activated CNS neuroglia contribute to neuroinflammation that can in turn contribute to 
central sensitization by impacting spinal circuits (Old et al., 2015). 
1.4. cAMP signaling in nociceptors 
 Cyclic adenosine monophosphate (cAMP) is a major mediator of intracellular 
signal transduction in response to a number of hormones, neurotransmitters, and 
inflammatory mediators that bind G protein-coupled receptors (GPCRs). GPCRs are a 
large family of receptors that use G proteins to transduce signals to their effectors, which 
include enzymes such as adenylyl cyclase (AC) and phospholipase C (PLC) as well as 
Ca2+ channels (Ross and Kenakin, 2001). The G proteins are comprised of two subunits 
– the α subunit and the βγ subunit. The major effector type and whether the activity of 
the effector is increased or decreased depends on the α subunit. Gαs stimulates AC 
activity, while Gαi inhibits AC activity; and Gαq stimulates PLC activity, leading to release 
of intracellular Ca2+ stores and activation of protein kinase C (PKC). Additionally, the 
Gβγ subunits regulate K+ channels, AC, PLC, and phosphatidyl inositol-3-kinase (PI3K). 
Ligands for GPCRs in sensory neurons include an array of biogenic amines (e.g. 
serotonin and histamine), eicosanoids (e.g. prostaglandins), lipids (e.g. cannabinoids), 
and peptides (e.g. opioids and vasoactive intestinal peptide). As a result of their 
abundance and physiological importance, GPCRs are common targets for therapeutics 
(Ross and Kenakin, 2001).  
 Several inflammatory mediators, including serotonin, activate GPCRs coupled to 
Gαs, which in turn activate AC, leading to pain sensitization acutely (Villarreal et al., 
2009). Recent studies also implicate signaling downstream of AC in the maintenance of 
chronic pain (Bavencoffe et al., 2016; Dessauer et al., 2017; Sadana and Dessauer, 
14 
 
2009; Vadakkan et al., 2006). AC synthesizes the second messenger cAMP from 
adenosine triphosphate (ATP). Cyclic AMP can then go on to activate its effectors – 
protein kinase A (PKA), exchange protein activated by cAMP (EPAC), hyperpolarization-
activated cyclic nucleotide-gated channels (HCN), and popeye domain containing 
proteins (POPDC). 
 The most extensively studied cAMP effector, PKA, plays an important role in pain 
sensitization and nociceptor ongoing activity by phosphorylating a multitude of targets, 
and can exact longer-term changes by modulating gene expression via the transcription 
factor cAMP-response element binding protein (CREB). PKA-activating inflammatory 
mediators or direct activation of PKA increases activity of channels involved in 
nociceptor hyperexcitability, including TRPV1, T-type Ca2+ channels, and tetrodotoxin-
resistant voltage-gated Na+ channels (Kim et al., 2006; Ohta et al., 2006; Vijayaragavan 
et al., 2004). PKA activation can also increase excitability by negatively regulating K+ 
channels that normally limit excitability and repetitive firing (Nuwer et al., 2010). 
Furthermore, inhibiting PKA activity or disrupting interaction with its AKAP scaffold in 
dissociated DRG neurons reduces nociceptor OA in a spinal cord injury model of 
neuropathic pain (Bavencoffe et al., 2016).  
 Recently, EPAC has also come to light as an important player with a role in the 
transition from acute to chronic pain. EPACs are guanine nucleotide exchange factors 
(GEFs) that catalyze the exchange of GDP for GTP for the Ras-like GTPases Rap1/2, 
thereby activating them. Downstream of EPAC-Rap, PLC and PLD mediate the 
translocation and activation of protein kinase C ε (PKCε) (Schmidt et al., 2001), which 
contributes to sensitization in neuropathic and chronic inflammatory pain (Dina et al., 
2001, 2000; Joseph and Levine, 2003a, 2003b; Khasar et al., 1999; Numazaki et al., 
15 
 
2002; Sweitzer et al., 2004). Thus, EPAC mediates a connection between cAMP and 
PKC signaling (Hucho et al., 2005), which were previously thought to function as two 
separate pathways. It is thought that a transition to increased downstream cAMP 
signaling via EPAC-PKC is involved in nociceptor priming, which is likely a key factor in 
the transition from acute inflammatory pain to chronic pain (Eijkelkamp et al., 2010; 
Hucho et al., 2005; Vasko et al., 2014; Wang et al., 2018). In addition to nociceptor 
priming and persistent pain, there is evidence for the involvement of EPAC in mediating 
acute inflammatory pain (Goode and Molliver, 2021). 
 HCN channels represent another cAMP effector that is widely expressed in the 
PNS and plays a role in neuronal excitability and pain transduction. As the name 
suggests, these channels are activated by hyperpolarization and modulated by cAMP. 
In response to hyperpolarization, they conduct Na+ ions into the cell (and K+ ions out of 
the cell), resulting in net depolarization, which causes the channel to close again. Thus, 
HCN channels have the capacity to act as pacemakers, a function typically associated 
with HCN in the heart. Furthermore, studies suggest HCN channels in nociceptors are 
critical players in inflammatory and neuropathic pain (Emery et al., 2011; Ma et al., 
2021).  
1.5. Conclusions 
 Ongoing spontaneous pain is a major complaint of patients suffering from many 
forms of acute and chronic pain. Ongoing activity in nociceptors is a major driver of 
ongoing pain in humans, and similar OA is observed in isolated nociceptors in rodent 
pain models. Three neurophysiological alterations contribute to OA in the absence of 
sensory generator potentials – depolarization of RMP, hyperpolarization of AP 
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threshold, and enhancement of depolarizing spontaneous fluctuations of the membrane 
potential (DSFs). OA can be enhanced acutely in nociceptors by inflammatory mediators 
released by immune and glial cells, such as serotonin, which will be discussed in detail 
in later chapters. Cyclic AMP is a major mediator of intracellular signal transduction in 
response to a number of hormones, neurotransmitters, and inflammatory mediators, and 
cAMP and its effectors PKA and EPAC are known contributors to persistent OA after 
spinal cord injury (Bavencoffe et al., 2016; Berkey et al., 2020; Garza Carbajal et al., 
2020). However, neuromodulators and cellular signaling pathways that increase DSF 
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All procedures were in accordance with the guidelines of the International 
Association for the Study of Pain and were approved by the Institutional Animal Care 
and Use Committee. Male Sprague-Dawley rats (200-300 g, 2 per cage) were 
maintained in the McGovern Medical School animal research facility under a 12:12 h 
reversed light/dark cycle, and experiments were performed during the dark phase. Rats 
had access to food and water ad libitum.  
2.2. Dissociation and culture of DRG neurons 
Rats were euthanized by intraperitoneal injection of pentobarbital/phenytoin (0.9 
mL; Euthasol, Virbac AH, Inc) followed by transcardial perfusion of ice-cold phosphate-
buffered saline (PBS, Sigma-Aldrich). DRG from spinal levels T8 to L6 (for 
pharmacological experiments) or L4 to L6 (for plantar incision experiments, keeping 
ipsilateral and contralateral DRG separate) were excised and digested with trypsin (0.3 
mg/mL, Worthington) and collagenase D (1.4 mg/mL, Sigma-Aldrich) in Dulbecco’s 
Modified Eagle Medium (DMEM; Sigma-Aldrich) for 40 min at 34C. Digested DRG were 
washed twice with warm (37C) DMEM followed by mechanical trituration in DMEM with 
fire-polished Pasteur pipettes. Dissociated cells were seeded on glass coverslips (for 
electrophysiological recordings or Ca2+ imaging) or a 96-well cell culture microplate (for 
high content microscopy) coated with poly-L-ornithine solution (0.01%). Cell cultures 
were incubated overnight (5% CO2, 95% humidity, 37C) in DMEM without serum, 




2.3. Whole-cell recordings from dissociated DRG neurons 
Small- to medium-sized DRG neurons (soma diameter 30 m and input 
capacitance 45 pF, to exclude most LTMRs and proprioceptors and patch 
predominantly nociceptors) that were not in visible contact with other neurons or debris 
were recorded in whole-cell configuration at room temperature using either a Zeiss 
Axiovert 200M with 40X magnification and a HEKA EPC10 amplifier or an Olympus IX-
71 with 40X magnification and a MultiClamp 700B amplifier (Molecular Devices). Patch 
pipettes were pulled from borosilicate glass capillaries with a 1.5 mm outer diameter and 
0.86 mm inner diameter (Sutter Instrument Co) using a Sutter P-97 Flaming/Brown 
Micropipette Puller followed by polishing. Patch pipettes were filled with an intracellular-
like solution (ICS; in mM: 134 KCl, 1.6 MgCl2, 13.2 NaCl, 3 EGTA, 9 HEPES, 4 Mg-ATP, 
and 0.3 Na-GTP, adjusted to pH 7.2 with KOH and osmolarity 300 with sucrose) and 
had an electrode resistance of 2-10 M. The extracellular solution (ECS) contained (in 
mM): 140 NaCl, 3 KCl, 1.8 CaCl2, 2 MgCl2, 10 HEPES, and 10 glucose and was adjusted 
to pH 7.4 with NaOH and osmolarity 320 with sucrose. After forming a tight seal, the 
membrane was ruptured to establish whole-cell configuration under voltage clamp, and 
membrane resistance and input capacitance were measured. The liquid junction 
potential (~4.3 mV) was not corrected.  
To measure OA at rest, neurons were recorded in current clamp with no current 
injection for a minimum of 1 min. Next, current was injected to maintain the membrane 
potential at approximately -60 mV while a series of 2-ms depolarizing current injections 
(200 ms sweep interval, +10 pA or +20 pA increments) were used to measure AP 
voltage threshold. This was followed by a series of 2-s depolarizing current injections 
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(4-s sweep intervals, increments of +5 pA, +10 pA, or +20 pA) to measure rheobase and 
to provide an additional measure of AP voltage threshold. Each of these procedures 
yields consistent estimates of AP voltage threshold (Odem et al., 2018); my primary 
measure was the AP threshold determined with 2-s pulses. To measure OA at -45 mV, 
current was injected to maintain a membrane potential of approximately -45 mV for at 
least 30 s. DSFs were quantified using our algorithm SFA.py coded in Python v3.5.2 
(Python Software Foundation), as described previously (Odem et al., 2018), from the 
30-s traces recorded at -45 mV. In addition to subthreshold DSFs identified by the 
program, suprathreshold DSFs were included, for which the amplitude was calculated 
as the difference between the start membrane potential of the event and the AP 
threshold. DSFs were not quantified from cells exhibiting firing frequencies above ~1.5 
Hz.  
For neurons treated with serotonin (5-HT, serotonin hydrochloride, Abcam and 
Sigma-Aldrich) or prucalopride (Sigma-Aldrich), recordings were made from cells that 
had been pre-exposed to the drug (at least 5 min), and the drug was continuously 
present during the recordings (up to 60 min). There was no apparent change in the 
effects on the properties measured over this period. To test the effects of 5-HT receptor 
antagonists, PKA inhibitors, EPAC inhibitors, or a hyperpolarization-activated cyclic-
nucleotide-gated channel (HCN) inhibitor, coverslips were incubated at 37C in ECS 
containing GR113808, ketanserin-tartrate salt, myristoylated PKI 14-22 amide (all from 
Sigma-Aldrich), RS127445, granisetron, SB269970, CE3F4, H-89, ZD7288 (all from 
Cayman Chemical), or ESI-05 (synthesized as described by Chen et al., 2013) for a 
minimum of 5 min before being transferred to the recording chamber containing the 
inhibitor plus 5-HT in ECS. With the exception of 8-Br-cAMP, all drugs were added to 
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the ECS. The chambers were not continuously perfused. 8-Br-cAMP (Sigma-Aldrich) 
was diluted in ICS for intracellular delivery via the patch pipette (resistance of 2-6 M). 
For intracellular dialysis of 8-Br-cAMP, after obtaining whole-cell configuration, the cell 
was maintained at -60 mV under voltage clamp for at least 3 min before switching to 
current clamp and proceeding with data collection.  
All data shown are from non-accommodating (NA) type neurons, excluding the 
rapidly accommodating (RA) type neurons (Odem et al., 2018). Thus, all 
electrophysiological data analyzed includes probable nociceptors (based on soma size) 
that are capable of repetitive firing. Additionally, our previous study using the same 
culture conditions and size selection criterion indicated 70% of NA neurons patched 
were sensitive to capsaicin and thus presumed TRPV1+ (Odem et al., 2018). 
2.4. High content microscopy and subpopulation analysis 
The following materials were used. Primary antibodies: chicken anti-PGP9.5 
(1:4000, Novus Biologicals, # NB110-58872), rabbit monoclonal anti-phospho RII (S99) 
(1:1000, clone 151, Abcam, # ab32390), and mouse anti-CGRP (1:1000, Santacruz 
#SC-57053). Secondary antibodies (all 1:1000): goat anti-chicken-DyLight 755, goat 
anti-rabbit 568, donkey anti-mouse AF 647. Isolectin B4-FITC (1:1500, MilliporeSigma, 
#L2895) and DAPI.  
Following pharmacological treatments at 37C, cells were fixed with 4% 
paraformaldehyde for 10 min then washed with PBS. Cells were then blocked for one 
hour at room temperature with blocking solution containing 1% bovine serum albumin 
and 0.075% Triton X-100 in PBS followed by incubation with primary antibodies in 
22 
 
blocking solution at 4C overnight. After washing, cells were incubated with secondary 
antibodies and DAPI in blocking solution or with isolectin B4 (IB4) in IB4 buffer (100 µM 
each MgCl2, CaCl2, and MnCl2 in PBS) at room temperature in the dark for one hour 
followed by three final PBS washes.  
Plates were imaged using a Cellomics CX5 microscope (Thermo Scientific) with 
a 10x objective following modified protocols described by Isensee et al. (2018, 2017, 
2014). Cellomics software package (Thermo Scientific) was used to analyze 1104x1104 
pixel images. Neurons were identified by PGP 9.5 staining intensity. When appropriate, 
bleed through between channels was compensated with raw fluorescence data from 
fluorescence controls using the slope determined by linear regression (Prism, 
GraphPad) as described by Roederer, 2002.  
One- and two-dimensional density plots were generated using FlowJo (Becton 
Dickinson). Gating of subpopulations, based on neuronal soma area, CGRP expression, 
and IB4 binding as established previously by Garza Carbajal et al. (2020), was 
performed by setting thresholds at local minima of probability in 2D plots and 
corroborated by 3D cluster analysis. Individual cells used to perform the cluster analysis 
were normalized between the minimal (0.001%) and maximal (0.999%) fluorescence 
levels per channel. Cluster analysis (k-medians) was performed using Cluster 3.0 
software (de Hoon et al., 2004). Three-dimensional (3D) plots were constructed using 
Plotly (Chart Studio). Data analysis and graph plots were performed using Prism.  
2.5. Ca2+ imaging 
Overnight cultured DRG neurons were loaded with 2 µM Fura-2AM 
(TEFLabs.com) in DMEM in the cell culture incubator for 1 hour. Neurons on coverslips 
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were placed in a diamond-shaped RC-40 low profile bath chamber on a QE-1 quick 
exchange platform (both from Warner Instruments) and were constantly perfused with 
the same ECS used for electrophysiological recording. Images were acquired on a live 
cell fluorescence system, including Nikon Eclipse TE2000-U microscope with 40X oil 
objective lens and a Sutter Instrument Lambda DG-4 ultra-high-speed wavelength 
switching system controlled by SlideBook software v5.0. Fura-2 fluorescence signals 
were excited alternately at 340 nm and 380 nm every 3 seconds and detected at 510 
nm emission. Serotonin (300 nM or 10 µM) or capsaicin (500 nM, Sigma-Aldrich) diluted 
in ECS or KCl (60 mM, made by substituting 57 mM NaCl from ECS with equimolar KCl) 
was applied to neurons through whole chamber perfusion by a peristaltic pump at a flow 
rate of approximately 2 ml/min. Serotonin was applied 90-120 secs following 2 min 
baseline recording. Capsaicin was applied following 5-HT stimulation to identify 
capsaicin-sensitive nociceptors. KCl was applied at the end of each recording to confirm 
responses from live neurons. Fura-2 fluorescence ratios (F340/F380) were analyzed 
using SlideBook to estimate intracellular Ca2+ concentration ([Ca2+]i) changes. 
2.6. Surgical procedures 
 Rats were anesthetized with isoflurane for plantar incision as described 
previously by Brennan, et al. (Brennan et al., 1995). Anesthesia was induced by placing 
the rat in a chamber filled with 4% isoflurane in air followed by 2% isoflurane via a nose 
cone maintained during surgery. The left hind paw was sterilized with alternating iodine 
swabs and alcohol pads. Beginning 0.5-1 cm from the proximal edge of the heel, a ~2 
cm longitudinal incision was made through the skin and fascia. The flexor digitorum 
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brevis muscle was then elevated and incised longitudinally, leaving intact the muscle 
origin and insertion. The skin was closed with two absorbable sutures.  
2.7. Measurement of guarding behavior 
 Rats were placed individually on an elevated metal mesh (grid 6 x 6 mm) and 
enclosed by a clear plastic cage top (20.5 x 20.5 x 13.5 cm). Both hind paws were closely 
observed for a 1-min period every 4 min for 48 min or every 3 min for 36 min, depending 
on the number of rats in each group. For each 1-min observation period a score of 0, 1, 
or 2 was given for each paw according to its position during the majority of the period. 
As described previously (Xu and Brennan, 2010), a score of 0 was given if the incised 
area was touching and being blanched or distorted by the mesh. A score of 1 was given 
if the incised area was touching the mesh without being blanched or distorted. A score 
of 2 was given if the incised area was completely off of the mesh. A sum score was 
obtained for each hind paw by adding the 12 scores observed during the 48-min or 36-
min testing period. The guarding score was obtained by subtracting the score of the 
uninjured paw from that of the injured paw.  
2.8. Statistical analysis 
All data sets were tested for normality with the Shapiro-Wilk and D’Agostino and 
Pearson tests. Normally distributed data were analyzed by parametric tests: t-test or 1- 
or 2-way ANOVA followed by Dunnett’s or Tukey’s multiple comparisons tests using 
Prism v8 (GraphPad Software, Inc). Non-normally distributed data were analyzed by 
non-parametric tests: Mann-Whitney or Kruskal-Wallis (GraphPad Software, Inc). If any 
data set within an analysis failed to pass either normality test, non-parametric statistics 
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were performed. Comparisons of incidences were made with Fisher’s exact test. All 
tests were two-tailed, with one exception. The dose-response relationship for 5-HT and 
OA was tested with a one-tailed Fisher’s exact test on the basis of prior observations 
indicating that the incidence of OA, which is low under our control conditions, would be 
increased but not decreased by 5-HT treatment. All t-tests were unpaired unless 
otherwise stated. Dose-response curves were fitted using Prism v8.  
2.9. RNA sequencing 
 Seven days after deep tissue plantar incision surgery, the L4-6 DRG were 
collected from naïve and incised rats, keeping the left (ipsilateral) and right 
(contralateral) sides separate. All surgeries took place in the morning, and tissue 
collection was carried out in the afternoon on postoperative day 7. To ensure an 
adequate amount of tissue for RNA extraction, DRG were pooled from 2 rats for each 
sample. Thus, each sample contained 6 DRG – unilateral L4-6 from 2 rats. Each 
condition had 4 replicates, so each condition was represented by 8 rats. Total RNA was 
extracted and purified using the RNeasy Mini Kit (Qiagen).  
RNA quantification and qualification, library preparation, sequencing, and 
bioinformatics analysis were performed by Novogene Co., Ltd in Sacramento, CA. 
Briefly, RNA degradation and contamination was monitored on 1% agarose gels. RNA 
purity was checked using the NanoPhotometer spectrophotometer (IMPLEN), and 
integrity and quantification were assessed using the RNA Nano 600 Assay Kit of the 
Bioanalyzer 2100 system (Agilent Technologies). A total of 1 µg RNA per sample was 
used as input materials for the RNA sample preparations. Sequencing libraries were 
generated using NEBNext Ultra RNA Library Prep Kit for Illumina (NEB). Library quality 
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was assessed on the Agilent Bioanalyzer 2100 system. Clustering of the index-coded 
samples was performed on a cBot Cluster Generation System using PE Cluster Kit cBot-
HS (Illumina), then library preparations were sequenced on an Illumina platform and 
paired-end reads were generated. Raw reads (FASTQ format) were processed through 
fastp to obtain clean reads by removing reads containing adapter and poly-N sequences 
and reads with low quality. Downstream analyses were based on the clean data with 
high quality. Paired-end clean reads were mapped to the reference genome (Rattus 
norvegicus) using HISAT2 software. Featurecounts was used to count the read numbers 
mapped of each gene, including known and novel genes, and FPKM of each gene was 
calculated based on the length of the gene and reads count mapped to the gene. 
Differential expression analysis between two groups was performed using DESeq2 R 
package. The resulting p values were adjusted using the Benjamini and Hochberg’s 
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As described in Chapter 1, pro-inflammatory mediators contribute to pain 
sensitization during injury and inflammation. One such mediator of interest is serotonin 
(5-hydroxytryptamine, 5-HT). Serotonin is well known for its important role as a 
neurotransmitter in the central nervous system in regulating mood and behavior. 
However, 5-HT mediates a wide variety of physiological functions both in the central 
nervous system and in the periphery, including gut motility, pain and inflammation, and 
other processes (Berger et al., 2009; Feldman, 2004; Sommer, 2004; Yadav, 2013). 
These two pools of 5-HT, one in the blood and periphery and one in the brain, function 
like two distinct molecules (Mann et al., 1992). Most of the 5-HT present in the periphery 
is synthesized in enterochromaffin cells of the gut (Gershon and Tack, 2007), where the 
rate-limiting step is the conversion of L-tryptophan to L-5OH-tryptophan by tryptophan 
hydroxylase (TPH). L-5OH-tryptophan is then converted to 5-HT by an aromatic L-amino 
acid decarboxylase (Mann et al., 1992; Walther et al., 2003). TPH1 carries out serotonin 
synthesis in the periphery, whereas TPH2 is responsible for serotonin synthesis in 
serotonergic neurons in the brain (Walther et al., 2003). 
Serotonin was linked to pain and nociceptor hyperexcitability in a number of 
previous studies. Intradermal application of 5-HT produces hyperalgesia in mice and 
rats (Lin et al., 2011; Taiwo and Levine, 1992) and pain in humans (Schmelz et al., 
2003). Serotonin application to dissociated DRG neurons can decrease the current 
needed to elicit an AP, increase the AP amplitude (Cardenas et al., 2001) and increase 
AP firing frequency during depolarizing current steps (Salzer et al., 2016). Several 
studies of 5-HT effects on nociceptor excitability have examined the effects of 
micromolar concentrations, often using relatively fast perfusion. Because exposure of 
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nociceptor somata to inflammatory mediators like serotonin may occur through 
prolonged exposure to low concentrations in the blood and/or cerebrospinal fluid (CSF), 
it is important to also examine the effects of relatively low concentrations over longer 
time periods. 
3.2. Results 
3.2.1. Dose-dependent relationship of the effects of 5-HT on hyperexcitability 
To examine the dose-response relationship of 5-HT effects on DRG neurons 
under conditions of relatively prolonged exposure, I examined the effects of different 
concentrations (from 0.1 nM to 10 µM) of 5-HT on functionally important excitability 
properties in probable nociceptors exposed to 5-HT for ~5-60 min. Consistent with 
earlier observations that low and high doses of 5-HT enhance a voltage-gated Na+ 
channel conductance (Cardenas et al., 1997; Gold et al., 1996), prolonged 5-HT 
treatment hyperpolarized the AP voltage threshold (Figure 3A; 1-way ANOVA, F(6,76) 
= 2.28, p = 0.045) at 10 nM and 100 nM compared to the vehicle control. Serotonin 
increased the incidence of medium- (3-5 mV) and large-amplitude (>5 mV) DSFs 
recorded while the membrane potential was held at approximately -45 mV under current 
clamp (Figure 3B; Kruskal-Wallis, p = 0.0024 and p = 0.018, respectively) at 
concentrations of 10 nM and 100 nM. The greatest increase in the incidence of OA at -
45 mV occurred at 100 nM 5-HT (Figure 3C; 1-sided Fisher’s exact test, p = 0.005). 
There were trends toward increased OA incidence with concentrations as low as 10 nM 
(p = 0.065) and as high as 10 µM 5-HT (p = 0.11). Furthermore, there was an overall 
effect of 5-HT across all doses in reducing the rheobase during 2-s depolarizing test 
pulses, although individual doses showed no significant effects (Figure 3D; Kruskal-
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Wallis, p = 0.048). None of the tested 5-HT concentrations produced significant effects 
on either RMP (Figure 3A; 1-way ANOVA, F(6,76) = 1.61, p = 0.16) or OA recorded at 






Figure 3. Dose-response effects of 5-
HT on RMP, AP threshold, DSFs, and 
OA. DRG neurons were treated with 5-
HT or vehicle before and during 
recording. Each concentration is 
represented by a minimum of 8 cells 
from at least 2 rats. P values listed 
under overall significance indicate the 
result of ANOVA, Kruskal-Wallis, or 
Fisher’s exact tests assessing the 
presence of an overall effect across all 
doses. (A) 5-HT effects on RMP and AP 
threshold. Mean ± SEM. * p < 0.05. (B) 
5-HT effects on the frequency of 
medium-amplitude (3-5 mV) and large-
amplitude (>5 mV) DSFs during 30-s 
depolarization to -45 mV. Mean ± SEM. 
* p < 0.05, ** p < 0.01. (C) 5-HT effects 
on the incidence of OA measured 
during a ≥ 60-s recording at RMP and 
then during a 30-s depolarization to -45 
mV. P values indicate the result of 
Fisher’s exact tests comparing no 5-HT 
to all 5-HT concentrations combined. * 
p < 0.0083 (after Bonferroni correction 
for 6 comparisons). (D) 5-HT effects on 
rheobase. Mean ± SEM. Kruskal-Wallis 
test revealed a significant overall 
difference, but Dunn’s test did not 
reveal differences at individual doses.  
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3.2.2. Exposure to 100 nM 5-HT potentiates OA in probable nociceptors, in part by 
enhancing DSFs 
The effect of 100 nM 5-HT, the dose that yielded the strongest potentiation of OA 
(Figures 3C, 4A), on DSFs was examined in detail. During 30-s depolarization to -45 mV 
both the frequency of large (>5 mV amplitude) DSFs and frequency of APs were strongly 
increased by 5-HT (Figure 4B; Mann-Whitney tests, p < 0.0001). The mean amplitude 
of all DSFs (at least 1.5 mV amplitude) was increased in neurons treated with 5-HT 
(Mann-Whitney, p < 0.0001), and DSFs were largest in cells that had OA at -45 mV 
(Figure 4C; Mann-Whitney, p < 0.0001). Representative traces illustrating DSFs and OA 
in probable nociceptors held at -45 mV are shown in Figure 4D. As illustrated by raster 
plots (Figure 5A1,B1), DSFs occurred randomly in the control and 5-HT-treated 
conditions, and 5-HT increased the frequency of medium-amplitude DSFs (Mann-
Whitney, p < 0.001), which rarely triggered APs (Figure 5A2), as well as the frequency 
of large-amplitude DSFs (Mann-Whitney, p < 0.0001), which frequently reach AP 






Figure 4. Potentiation by 5-HT of OA in probable nociceptors. Dorsal root 
ganglion neurons from naive rats (n = 4) were treated with vehicle or 100-nM 5-HT 
for 10 to 30 minutes before and during each recording. After measurement of any SA, 
extrinsically driven OA was modeled by depolarization to -45 mV under current clamp 
for 30 to 60 seconds. (A) Pretreatment with 5-HT did not induce OA at RMP but 
significantly increased OA at -45 mV (the Fisher exact test). (B) In neurons tested at 
-45 mV, 5-HT significantly increased AP frequency during OA and large DSF 
frequency. Black lines-medians. (C) 5-HT increased the amplitude of DSFs measured 
at -45 mV, and the neurons with OA showed larger DSFs than silent neurons. 
Depolarizing spontaneous fluctuation sample sizes left to right: 1360, 2113, 1256, 
and 2217. Data are shown as mean +/- SEM. *** p < 0.001 **** p < 0.0001. (D) 
Representative recordings SFs and OA at -45 mV after treatment with vehicle or 5-
HT. Insets: enlarged sections from each trace. AP, action potential; DSF, depolarizing 
spontaneous fluctuation; MP, membrane potential; OA, ongoing activity; RMP, resting 
membrane potential; SA, spontaneous activity. Data collected by Elia R. Lopez, DSF 





These results show that OA and two of its major electrophysiological mechanisms 
(increased DSF amplitude and decreased AP voltage threshold) in probable nociceptors 
are sensitive to relatively low concentrations of 5-HT. In addition, the results confirm 
Figure 5. Treatment with 5-HT before and during recording at -45 mV increases 
the number of medium amplitude and large DSFs in probable nociceptors from 
naive rats. (A1, B1) Raster plots of medium amplitude and large DSFs during 
depolarization to -45 mV. Each row represents one neuron and each point a single 
DSF. (A2, B2) At -45 mV, 5-HT increased the number of medium amplitude and large 
DSFs, and the percentage of DSFs evoking APs. Bars represent the mean +/- SEM 
or fraction in total sample, and significance was tested using Mann-Whitney U or 
Fisher exact tests. * p < 0.05, *** p < 0.001, **** p < 0.0001. Neurons are from the 
naive rats (n = 4) used in Figure 6. AP, action potential; DSF, depolarizing 
spontaneous fluctuation. Data collected by Elia R. Lopez, DSF analysis and figure by 
Max A. Odem. 
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that, while these 5-HT concentrations enhance AP generation by at least two general 
electrophysiological alterations, this enhancement is only expressed when the 
membrane potential is maintained at a relatively depolarized level within the 
physiological range. Thus, prolonged (5-60 min) application of 100 nM 5-HT combined 
with an extrinsic source of depolarization (to -45 mV) for 30-60 sec provides a useful 
















Note: Figures and text are partially reprinted from E. R. Lopez, A. Garza Carbajal, J. B. 
Tian, A. Bavencoffe, M. X. Zhu, C. W. Dessauer, and E. T. Walters. 2021. Serotonin 
enhances depolarizing spontaneous fluctuations, excitability, and ongoing activity in 
isolated rat DRG neurons via 5-HT4 receptors and cAMP-dependent mechanisms. 
Neuropharmacology 184: 108408.  Use of the text and figures are granted for use in a 




While 5-HT-stimulated cell signaling that may lower AP threshold in nociceptors 
has been explored (Cardenas et al., 2001; Gold et al., 1996), cell signaling pathways 
that enhance DSFs and OA acutely have not been described. Multiple signaling 
pathways have been implicated in 5-HT effects on nociceptor excitability and pain, 
potentially linked to numerous 5-HT receptors expressed in the DRG, including those 
coupled to Gs, Gi, and Gq, as well as 5-HT-gated cation channels (Chen et al., 1998; Lin 
et al., 2011; Nicholson et al., 2003; Ohta et al., 2006). My objective was to define the 
predominant cell signaling mechanism by which 5-HT enhances DSFs and associated 
OA. Because 5-HT is known to strongly activate PKA in nociceptors (Isensee et al., 
2017) and our previous studies linked PKA and EPAC activity to chronic pain-related 
OA (Bavencoffe et al., 2016; Berkey et al., 2020), I hypothesized that Gs-coupled 5-HT 
receptors (5-HTR) mediate the enhancement of DSFs, reduction of AP threshold, and 
consequent potentiation of OA by 5-HT.  
4.2. Results 
4.2.1. 5-HT4 receptors are required for potentiation of DSFs and OA induced by 
5-HT 
To begin to elucidate the cell signaling pathways by which 5-HT modulates DSFs 
and AP threshold, and their effects on OA, I asked which 5-HT receptors are required. 
Selective antagonists of 5-HT receptors known to be expressed in the DRG were added 
to the 5-HT solution. The incidence of OA recorded at -45 mV in the presence of 100-
300 nM 5-HT was blocked by the selective 5-HT4 receptor antagonist GR113808 (Figure 
6A, B; Fisher’s exact test, p = 0.0002) but not by the other 5-HT receptor antagonists 
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tested. GR113808 reduced the frequencies of medium-amplitude (3-5 mV; Kruskal-
Wallis, p = 0.01) and large-amplitude (>5 mV; Kruskal-Wallis, p = 0.0007) DSFs at -45 
mV during exposure to 5-HT (Figure 6C). Additionally, treatment with GR113808 
resulted in a more depolarized AP threshold in the presence of 5-HT compared to 
vehicle/5-HT (Figure 6D; Kruskal-Wallis, p = 0.024). Moreover, GR113808 prevented 
reduction of the rheobase by 5-HT (Figure 6E; Kruskal-Wallis, p = 0.0099). Selective 
antagonists of 5-HT2A/2C (ketanserin), 5-HT2B (RS127445) or 5-HT3 (granisetron) had no 
effect on any of these measures (Figure 6A, C, D), and there was no significant effect 
on RMP by any of the agents tested (Figure 6F; Kruskal-Wallis, p = 0.1963).  
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  Figure 6. 5-HT4 receptor is required for potentiation of DSFs and OA by 5-HT. 
Cells were pre-treated for 5-15 min with 1 µM of the 5-HTR antagonist or vehicle control 
before cells were patched in the presence of the antagonist plus 100-300 nM 5-HT. (A) 
Representative recordings at -45 mV in different neurons exposed to vehicle/5-HT or 
GR113808/5-HT. Note the two APs (OA) and large DSFs in the left panel. MP = 
membrane potential. (B) 5-HTR antagonist effects on the incidence of OA during 
exposure to 5-HT. OA was measured at RMP for ≥60 s then during depolarization to -
45 mV for 30 s. *** p < 0.00025 (after Bonferroni correction for 4 comparisons). (C-E) 
5-HTR antagonist effects on the frequency of medium- (3-5 mV) and large-amplitude 
(> 5 mV) DSFs during 30-s depolarization to -45 mV (C), AP threshold (D), rheobase 
(E), and RMP (F) in the presence of 5-HT. Mean ± SEM. * p < 0.05. ** p < 0.01. 
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In high-content imaging studies using PKA-pRII as a surrogate readout of PKA 
activation (Isensee et al., 2014), the selective 5-HT4 antagonist GR113808 blocked PKA 
activation in response to 100 nM 5-HT in a dose-dependent manner (Figure 7; IC50 = 
5.55 nM; 2-way ANOVA, F(16,63) = 3.18, p = 0.0005), confirming a previous report 
(Isensee et al., 2017). Surprisingly, although there is evidence for expression of the Gs-
coupled 5-HT7 receptor in rodent and human DRG neurons (Chen et al., 1998; Lin et 
al., 2011; Morita et al., 2015; Ohta et al., 2006), and the selective 5-HT7 agonist LP44 
can evoke AP firing, albeit at a high concentration (Morita et al., 2015), I found that a 
selective antagonist of 5-HT7 (SB269970) had no appreciable effect on PKA activation 
by 5-HT (Figure 7). As expected, 5-HT2A/2C (ketanserin), 5-HT2B (RS127445) and 5-HT3 
(granisetron) antagonists had no significant effect on PKA activation (Figure 7). These 
results suggest that, at these 5-HT concentrations, the Gs-coupled 5-HT7 receptor does 
not play a role in PKA activation in primary DRG neurons, and the Gq-coupled receptors 
(5-HT2) and 5-HT-gated cation channels (5-HT3) do not alter PKA activation produced 






To further address whether Gq-coupled 5-HT2 receptors might contribute to 
nociceptor responses to 5-HT under these potentially desensitizing electrophysiological 
testing conditions (relatively slow delivery and continuing exposure to 5-HT for at least 
several minutes), we measured Ca2+ responses to 5-HT in probable nociceptors using 
Fura-2. Example recordings from a neuron that failed to respond to 90-120 s superfusion 
with either 300 nM or 10 µM 5-HT and another neuron that showed a weak response to 
the higher concentration are shown in Figure 8A. Only 5.6% (2/36) and 9.7% (3/31) of 
neurons responsive to capsaicin (i.e. probable nociceptors) showed detectable 
increases in [Ca2+]i during superfusion with 300 nM or 10 µM 5-HT, respectively (Figure 
8B). Among the capsaicin-insensitive neurons, 0% (0/11) and 33.3% (2/6) showed an 
increase in [Ca2+]i in response to 300 nM or 10 µM 5-HT, respectively. These 
observations indicate that increasing 5-HT concentration relatively slowly (over tens of 
Figure 7. PKA activation measured by PKA-pRII staining in rat DRG neurons. 
Different concentrations of antagonists were applied 30 min prior to 5-min co-
application of the antagonist and 100 nM 5-HT. Each data point represents the mean 
± SEM of 3-5 separate experiments. **** p < 0.0001. 
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seconds under our superfusion conditions) elicits Ca2+ responses in only a small subset 
of DRG neurons (4.3 and 13% of all neurons tested in 0.3 and 10 µM 5-HT, respectively). 
Taken together, these data indicate that DSFs and associated OA are enhanced in a 
sustained manner by relatively low concentrations of 5-HT that fail to evoke Ca2+ 
responses in most of the neurons sampled, and these effects are mediated primarily by 
the Gs-coupled 5-HT4 receptor. 
 
4.2.2. Selective 5-HT4 activation can induce hyperexcitability in DRG neurons 
Is selective activation of the 5-HT4 receptor sufficient to enhance DSFs and 
promote OA in small DRG neurons? To answer this question, I used a selective 5-HT4 
agonist, prucalopride, and compared the dose dependence of its activation of PKA to 
the activation of PKA by 5-HT, along with the inhibition of these effects by an effective 
Figure 8. Ca2+ responses to 5-HT measured by Fura-2. (A) Representative traces 
of Fura-2 ratio changes used to indicate increases in [Ca2+]i during superfusion of 300 
nM or 10 µM 5-HT in single capsaicin-sensitive neurons. (B) Incidence of 5-HT-
associated increases in [Ca2+]i as measured with Fura-2. Cap-sens = capsaicin 
sensitive. Cap-insens = capsaicin-insensitive. Lo 5-HT = 300 nM 5-HT. Hi 5-HT = 10 




dose of the 5-HT4 receptor antagonist GR113808 (Figure 9). Activation of PKA by 
prucalopride and 5-HT exhibited a similar dose dependence, with an EC50 of 4.53 (95% 
confidence interval (CI) = 1.78 – 11.45, R2 = 0.89) for 5-HT and 10.23 nM (95% CI = 
4.06 – 25.61, R2 = 0.89) for prucalopride. A 2-way ANOVA revealed significant overall 
effects of dose (F(5,48) = 38.83, p < 0.0001) and drug (F(3,48) = 56.32, p < 0.0001). 
Importantly, GR113808 (1 µM) significantly reduced PKA activation by both 5-HT and 
prucalopride at all doses ≥ 10 nM and ≥ 100 nM, respectively (Figure 9). 
 
Figure 9. Dose-dependent PKA activation by 5-HT and the 5-HT4 agonist 
prucalopride. Vehicle (DMSO) or 1 µM GR113808 was co-applied with 5-HT or 
prucalopride for 5 min. Each data point represents the mean ± SEM of 3 separate 
experiments. Asterisks indicate significant difference of the agonist dose compared 
to no agonist. Hash marks indicate significant difference in the presence of antagonist 
compared to no antagonist. ** p < 0.01, ### p < 0.001, ****/#### p < 0.0001. Ppr, 
prucalopride; GR, GR113808. 
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Exposure to prucalopride (300 nM, ~5-60 minutes), like 5-HT, had no effect on 
RMP (Figure 10A; Mann-Whitney, p = 0.79) and did not induce OA at rest (Figure 10B). 
Prucalopride strongly increased the incidence of OA upon depolarization to -45 mV 
(Figure 10B, C; Fisher’s exact test, p = 0.0002). The modest experimental depolarization 
also revealed increases in mean DSF amplitude (Figure 10C, D; Mann-Whitney, p = 
0.0006) and increased frequencies of medium- and large-amplitude DSFs (Figure 10E; 
Mann-Whitney, p = 0.0022 and p = 0.0014, respectively), similar to that observed with 
comparable concentrations of 5-HT (Figure 3, Figure 5). Prucalopride significantly 
hyperpolarized AP voltage threshold (Figure 10F; Mann-Whitney, p = 0.0036) and 







Figure 10. Effects of prucalopride on hyperexcitability of probable nociceptors. 
(A) Lack of effect of prucalopride on RMP measured during electrophysiological 
recordings from cells continuously exposed to 300 nM prucalopride before and during 
recording. Mean ± SEM. (B) Effect of prucalopride on the incidence of OA determined 
from ≥60-s recordings at RMP then 30-s recordings at ~-45 mV. *** p < 0.001. (C) 
Representative traces of neurons treated with vehicle (DMSO) or prucalopride and 
depolarized to -45 mV. (D, E) Effects of prucalopride on the mean DSF amplitude and 
the frequency of medium- (3-5 mV) and large-amplitude (> 5 mV) DSFs during 30-s 
depolarization to -45 mV. Mean ± SEM. ** p < 0.01 *** p < 0.001. (F) Effect of 
prucalopride on the AP voltage threshold. Mean ± SEM. * p < 0.05. (G) Effect of 
prucalopride on the rheobase. Mean ± SEM. ** p < 0.01. 
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DRG neurons comprise several distinct subpopulations, even when excluding 
large cells as done in our patch clamp experiments. Therefore, I used a high-content 
microscopy approach to examine 5-HT4-induced PKA responses in DRG neuron 
subpopulations, as distinguished by the markers CGRP (for peptidergic nociceptors) 
and IB4-binding (for non-peptidergic nociceptors), as well as soma size (Garza Carbajal 
et al., 2020). The strongest PKA activation by prucalopride occurred in the 
nonpeptidergic nociceptors (IB4, 2.2-fold increase, paired t test, p = 0.0042), followed 
by an apparently weaker but still significant response in neurons positive for both IB4 
binding and CGRP (IB-CG, 1.5-fold increase, paired t test, p = 0.011); no response was 
observed in the peptidergic nociceptors (CGRP), small- to medium-sized neurons 





These results indicate that activation of 5-HT4 receptors is both necessary and 
sufficient to activate PKA and to promote larger DSFs, reduce AP threshold, and 
Figure 11. Selective 5-HT4 
receptor activation of PKA in DRG 
neuron subpopulations. (A) 
Examples of cell staining for PKA-
pRII. Scale bar = 25 µm. (B) PKA-RII 
phosphorylation in controls, 300 nM 
5-HT and 300 nM prucalopride, 
shown as coordinates of soma area 
(X-axis), CGRP staining intensity (Y-
axis), and IB4 staining intensity (Z-
axis). n > 15,000 neurons. (C) 
Prucalopride responses measured 
by PKA-pRII levels in specific 
neuronal subpopulations: N 
(negative for IB4 and CGRP and 
small somata), CGRP, IB-CG (weak 
staining for both IB4 and CGRP), 
L,XL (large and extra-large somata), 
and IB4. Each point represents the 
mean from one experiment 
normalized to the subpopulation 
baseline from the same experiment 
(n = 4 rats). * p < 0.05 ** p < 0.01. 
Figures in panels A and B made by 
Anibal Garza Carbajal.  
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increase the incidence of OA under depolarized conditions in response to 5-HT, and that 
this modulation is specific to IB4+ and IB4+/CGRP+ nociceptors.  
Numerous 5-HT receptors are expressed in primary somatosensory neurons and 
several have been implicated in peripheral sensitization (Loyd et al., 2013). For 
example, the 5-HT2A antagonist ketanserin can attenuate 5-HT-induced thermal 
hyperalgesia (Tokunaga et al., 1998), and a 5-HT2B/C antagonist can inhibit 5-HT-
induced mechanical allodynia but not 5-HT-induced thermal hyperalgesia in rodents (Lin 
et al., 2011). It is known from overexpression studies in HEK293T cells that 5-HT can 
produce robust Ca2+ transients via 5-HT2 receptors (Lin et al., 2011). Fast superfusion 
of 10 µM 5-HT produced rapidly activating and inactivating [Ca2+]i responses in 67% of 
capsaicin-sensitive neurons tested in rats (Linhart et al., 2003), in contrast to the lack of 
effect we found with the 5-HT2 antagonist on effects of 5-60 min bath application of 100-
300 nM 5-HT. Similarly, only 3.4% of mouse DRG neurons responded to 1 µM 5-HT with 
an increase in [Ca2+]i (Lin et al., 2011). However, significant [Ca2+]i responses to 5-HT 
were reported in capsaicin-sensitive rat trigeminal ganglion neurons, which were 
attenuated by antagonists of 5-HT2A receptors and 5-HT3 receptors (Loyd et al., 2011). 
Ionotropic 5-HT3 receptors typically activate and desensitize rapidly. In rat DRG 
neurons, a 5-HT2 antagonist abolished increased AP discharge during depolarizing 
steps produced by rapid perfusion of 10 µM 5-HT (Salzer et al., 2016).  
Different results among these and other studies might be explained by 
procedural, species, and sex differences, but it seems likely that a major factor 
contributing to the lack of action potentials or calcium responses evoked by 5-HT at 
RMP in our experiments arose from our attempt to mimic sustained exposure to 5-HT 
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likely to occur during in vivo inflammation. Slow, prolonged administration of 5-HT is 
likely to substantially desensitize many 5-HT receptors in nociceptors. In addition, 5-HT2 
and 5-HT4 receptors may function in partially separate nociceptor subpopulations, as 5-
HT2A receptors are mainly expressed in CGRP-synthesizing (peptidergic) small DRG 
neurons (Okamoto et al., 2002), while we found 5-HT4-induced PKA-RII phosphorylation 
(used here as an indirect measurement of cAMP generation) to be largely restricted to 
IB4+ (nonpeptidergic) and IB4+/CGRP+ nociceptors. In mice, 5-HT4 receptor expression 
was also shown by single-cell RNA-seq profiling to be restricted to nonpeptidergic DRG 
neurons (Linnarsson Lab, Mousebrain.org; Usoskin et al., 2015).  
In addition to the 5-HT4 family of Gs-coupled receptors, there is evidence for DRG 
neuron expression of Gs-coupled 5-HT7 and 5-HT6 receptors. 5-HT7 activity can 
potentiate T-type Ca2+ current via PKA-dependent mechanisms in Xenopus oocytes co-
expressing 5-HT7 and Cav3.2 (Kim et al., 2006), and a 5-HT7 agonist mimics potentiating 
effects of 5-HT on increases of [Ca2+]i evoked by capsaicin in DRG neurons (Ohta et al., 
2006). Functionally, 5-HT7 is linked to acute and chronic itch but not pain behaviors in 
mice (Morita et al., 2015). We were unable to block 5-HT activation of PKA in DRG 
neurons with a selective 5-HT7 antagonist (SB269970), suggesting 5-HT7 activity in 
these neurons is not a major contributor to cAMP signaling evoked by low concentrations 
of 5-HT.  
The evidence for expression of 5-HT6 receptors in rat lumbar DRG is mixed. For 
example, 5-HT6 receptor mRNA was reported to be increased after plantar injection of 
bee venom (Liu et al., 2005) and was detected above the noise level in my RNA 
sequencing study of rat DRG (see Chapter 6), but 5-HT6 receptor mRNA was not 
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detected in rat DRG neurons by in situ hybridization (Nicholson et al., 2003) or in 
cultured DRG neurons by RT-PCR (Chen et al., 1998). Because of the close similarity 
of the effects of the 5-HT4 receptor agonist prucalopride to those produced by 5-HT, and 
the complete blockade of 5-HT-induced OA, DSF enhancement, and PKA activation by 
the 5-HT4 receptor antagonist GR113808, I conclude that other Gs-coupled 5-HT 
receptors are less important under conditions used in my experiments, although 
potential contributions of 5-HT6 receptors have not been tested directly.  
Besides Gs- and Gq-coupled receptors, DRG neurons express Gi-coupled 5-HT1/5 
receptors. Any 5-HT1/5-mediated effects on OA remain to be elucidated and they may 
be complex because Gi-coupled receptors usually decrease cAMP signaling, and they 

















Note: Figures and text are partially reprinted from E. R. Lopez, A. Garza Carbajal, J. B. 
Tian, A. Bavencoffe, M. X. Zhu, C. W. Dessauer, and E. T. Walters. 2021. Serotonin 
enhances depolarizing spontaneous fluctuations, excitability, and ongoing activity in 
isolated rat DRG neurons via 5-HT4 receptors and cAMP-dependent mechanisms. 
Neuropharmacology 184: 108408. Use of the text and figures are granted for use in a 




Downstream of 5-HT4 activation, cAMP production is increased, leading to 
activation of its effectors, among which PKA is best known (Isensee et al., 2017). The 
results I presented in Chapter 4 confirmed the activation of PKA by relatively low 
concentrations of 5-HT (Figure 9). PKA activity has previously been implicated in 5-HT 
effects on voltage-dependent Na+ current that should reduce AP voltage threshold and 
rheobase (Cardenas et al., 2001; Gold et al., 1996). Besides 5-HT, other injury- and 
inflammation-related signals, such as prostaglandins, also bind Gs-coupled receptors, 
leading to increased cAMP production and pain sensitization (Cui and Nicol, 1995; 
Ferreira et al., 1978; Hingtgen et al., 1995). In this study, a pharmacological approach 
was taken to examine the individual roles of the three major cAMP effectors - PKA, 
EPAC, and HCN - in 5-HT effects on nociceptor hyperexcitability and to examine the 
effects of general activation of cAMP signaling using a cAMP analog. 
5.2. Results 
5.2.1. PKA activity is required for potentiation of DSFs and OA by 5-HT  
To test the necessity of PKA activity for 5-HT’s effects on OA, DSFs, AP voltage 
threshold, and rheobase, I utilized two different types of PKA inhibitor: H-89, a small-
molecule competitive inhibitor, and myr-PKI 14-22, a peptide that mimics endogenous 
PKA inhibitors. Both H-89 and PKI blocked 5-HT potentiation of OA at -45 mV (Figure 
12A; Fisher’s exact tests, p = 0.01 and p = 0.0051, respectively). Similarly, H-89 and 
PKI both attenuated the frequency of medium-amplitude DSFs (3-5 mV; Kruskal-Wallis, 
p = 0.0008) and large-amplitude DSFs (>5 mV; Kruskal-Wallis, p = 0.0018) at -45 mV 
(Figure 12B). PKI effectively blocked hyperpolarization of the AP voltage threshold by 
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5-HT (Figure 12C; Kruskal-Wallis, p = 0.0036). However, inhibition of PKA activity was 
not sufficient to significantly block the reduction of rheobase by 5-HT (Figure 12D; 
Kruskal-Wallis, p = 0.11). As anticipated, none of these treatments affected RMP (Figure 
12C) or incidence of OA at RMP (Figure 12A). These results demonstrate that PKA 
plays a critical role in enhancement of DSFs, reduction of AP threshold, and associated 




Figure 12. PKA activity is 
required for potentiation of 
DSFs and OA by 5-HT. Rat DRG 
neurons were treated with 10 µM 
H-89, 1 µM myr-PKI 14-22, or 
vehicle before and during 
exposure to 100-300 nM 5-HT. (A) 
Effects of H-89 and PKI on the 
incidence of OA during 5-HT 
exposure. The occurrence of OA 
was determined from ≥ 60-s 
recordings at RMP then 30-s 
recordings at ~-45 mV. * p < 0.025 
(after Bonferroni correction for 2 
comparisons). (B-D) Effects of H-
89 and PKI on the frequency of 
medium- (3-5 mV) and large-
amplitude (>5 mV) DSFs during 
30-s depolarization to -45 mV (B), 
AP voltage threshold (C), and 
rheobase (D) in the presence of 5-
HT. Mean ± SEM. ** p < 0.01.  
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5.2.2. EPAC activity contributes to induction of hyperexcitability by 5-HT  
While PKA is the cAMP effector best known for enhancing nociceptor activity and 
pain, important roles are also played by EPAC (Berkey et al., 2020; Fu et al., 2019; 
Huang and Gu, 2017; Pan et al., 2019; Singhmar et al., 2018). The relationship between 
5-HT signaling and EPAC activity has begun to be elucidated in the brain and spinal 
cord (Cochet et al., 2013; Fields et al., 2015; Lin et al., 2003), but whether EPAC activity 
is involved in 5-HT effects on DRG neurons is unknown. To test this possibility, I 
employed an EPAC1 inhibitor, CE3F4, and EPAC2 inhibitor, ESI05, alone and in 
combination. Significant attenuation of OA generated at -45 mV in the presence of 5-HT 
was only observed with combined CE3F4/ESI05 treatment (Figure 13A; Fisher’s exact 
test, p = 0.002), although there was a trend toward reduced OA incidence with ESI05 
alone (p = 0.032, not significant after Bonferroni correction for multiple comparisons). 
Similarly, the frequency of large-amplitude (>5 mV) DSFs at -45 mV in the presence of 
5-HT was significantly attenuated by the combination of CE3F4 and ESI05 (Figure 13B, 
right panel; Kruskal-Wallis, p = 0.017). No significant attenuation of medium-amplitude 
DSFs (Figure 13B, left; Kruskal-Wallis, p = 0.24) or AP threshold (Figure 13C) was 
observed, but possible trends toward more depolarized AP thresholds in the presence 
of 5-HT were observed with CE3F4 or ESI05 alone or in combination (1-way ANOVA, 
F(3,87) = 2.23, p = 0.091). Weak individual effects of EPAC1 and EPAC2 on AP 
threshold and DSFs might combine to produce significant effects on OA. No effect of 
EPAC inhibitors was found on 5-HT-induced reduction of rheobase (Fiure.13D; Kruskal-
Wallis, p = 0.92), and none of these treatments impacted RMP (Figure 13E; Kruskal-
Wallis, p = 0.89). Taken together, these findings suggest that EPAC activity contributes 
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to the increases in DSF amplitude and incidence of OA caused by 5-HT under 
depolarized conditions.  
 
 
Figure 13. EPAC activity contributes to hyperexcitability induced by 5-HT. Cells 
were treated with CE3F4 (10 µM) or ESI-05 (5 µM) alone or in combination or vehicle 
control before and during exposure to 100-300 nM 5-HT. (A) Effects of EPAC 
inhibitors on the incidence of OA was measured during ≥60-sec recordings at RMP 
then during 30-sec depolarization to -45 mV in the presence of 5-HT. ** p < 0.0033 
(Bonferroni correction for 3 comparisons). (B) Effects of EPAC inhibitors on the 
frequency of medium- (3-5 mV) and large-amplitude (>5 mV) DSFs during 30-sec 
depolarization to -45 mV in the presence of 5-HT. Mean ± SEM. * p < 0.05. (C) Effects 
of EPAC inhibitors on the AP voltage threshold during exposure to 5-HT. Mean ± SEM. 




5.2.3. Nociceptor hyperexcitability induced by 5-HT does not require HCN activity  
The other major cAMP effector known to impact neuronal activity is the HCN 
channel. HCN channels may contribute modestly to RMP in nociceptors (Du et al., 
2014), and they are known to be important for some forms of pain (Emery et al., 2011; 
Weng et al., 2012). To examine whether HCN plays a role in enhancement of DSFs 
caused by 5-HT, I tested the effects of blocking this channel with a widely used HCN 
inhibitor, ZD7288 (e.g., Du et al., 2014), before and during exposure to 5-HT. ZD7288 
had no significant effect on the incidence of OA at -45 mV (Figure 14A; Fisher’s exact 
test, p = 0.26), frequency of medium- and large-amplitude DSFs at -45 mV (Figure 14B; 
Mann-Whitney, p = 0.28 and p = 0.32, respectively), firing frequency at -45 mV (Figure 
14C; Mann-Whitney, p = 0.13), AP threshold (Figure 14D; t test, p = 0.64), or rheobase 
(Figure 14E; t test, p = 0.39), during exposure to 5-HT. These results suggest that HCN 
activity is not a major contributor to the effects of 5-HT on OA, DSFs, AP threshold, or 
rheobase in DRG neurons. Unexpectedly, the RMP was more depolarized in the 
presence of ZD7288 and 5-HT compared to 5-HT alone (mean = -60.9 mV and -67.8 
mV, respectively; Mann-Whitney test, p = 0.0012; data not shown). This was surprising 
because ion current through HCN channels in this range of membrane potentials would 
be expected to be depolarizing, leading to the expectation that blocking the channels 
would hyperpolarize RMP. Although the significance of this unexpected depolarization 
of RMP is unknown, it adds to my evidence that 5-HT’s effects on HCN signaling do not 





5.2.4. Activation of cAMP signaling is sufficient to induce hyperexcitability in 
probable nociceptors 
While we know that cAMP signaling is important for maintaining chronic 
nociceptor hyperactivity in vitro after spinal cord injury (Bavencoffe 2016; Berkey 2020), 
Figure 14. Nociceptor hyperexcitability induced by 5-HT does not require HCN 
activity. Rat DRG neurons were treated 100 µM ZD7288 before and during exposure 
to 100 nM 5-HT. (A) Effect of ZD7288 on the incidence of OA during exposure to 5-
HT. The occurrence of OA was measured during ≥60-sec recordings at RMP then 
during 30-sec depolarization to -45 mV. (B-E) Effects of ZD7288 on the frequency of 
medium- (3-5 mV) and large-amplitude (>5 mV) DSFs during 30-sec depolarization 
to -45 mV (B), frequency of AP firing during 30-sec recordings at -45 mV (C), AP 
voltage threshold (D), and rheobase (E) in the presence of 5-HT. Mean ± SEM. 
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and that 5-HT and PGE2 stimulate cAMP signaling in nociceptors, it is not known 
whether an acute increase in cAMP, which can occur downstream of a number of 
receptors for various algogenic ligands, is sufficient to promote larger DSFs and OA. To 
answer this question, I applied the cAMP analog 8-Br-cAMP intracellularly via the patch 
pipette. Similar to extracellular application of 5-HT, intracellular dialysis of 8-Br-cAMP 
did not induce OA at rest, but it increased the incidence of OA when the neuron was 
experimentally depolarized to a holding potential of ~-45 mV (Figure 15A; Fisher’s exact 
test, p = 0.028) and reduced the rheobase (Figure 15D; t test, p = 0.013). Also similar 
to 5-HT, 8-Br-cAMP increased the frequency of medium- (3-5 mV) and large-amplitude 
(>5 mV) DSFs at -45 mV (Figure 15B; Mann-Whitney, p = 0.0001 and p = 0.0024, 
respectively) and hyperpolarized the AP voltage threshold (Figure 15C; Mann-Whitney, 
p = 0.016). Unlike 5-HT or the selective 5-HT4 agonist prucalopride, 8-Br-cAMP 
significantly depolarized the RMP (Figure 15E; t test, p = 0.0085), indicating that 
activation of the cAMP signaling pathway can affect RMP (see also Momin and 






Figure 15. Activation of cAMP signaling by the cAMP analog 8-Br-cAMP is 
sufficient to potentiate DSFs and OA in isolated DRG neurons. Patch pipettes 
contained 100 µM 8-Br-cAMP or vehicle in the ICS. (A) Effect of 8-Br-cAMP on the 
incidence of OA. The occurrence of OA was measured during ≥60-sec recording at 
RMP then during 30-sec depolarization to -45 mV. * p < 0.05. (B-E) Effect of 8-Br-
cAMP on the frequency of medium- (3-5 mV) and large-amplitude (>5 mV) DSFs 
during 30-sec depolarization to -45 mV (B), AP threshold (C), rheobase (D), and RMP 
(E). Mean ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001. 
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 The inhibitors of effectors downstream of cAMP that produced the largest 
attenuation of 5-HT-induced hyperexcitability were inhibitors of PKA, which blocked 
enhancement of OA, DSFs, and excitability by 5-HT. PKA activity was previously linked 
to potentiation by 5-HT of transient receptor potential V1 (TRPV1) function (Ohta et al., 
2006) and tetrodotoxin-resistant (TTX-R) Na+ current (Scroggs, 2011) in isolated DRG 
neurons, as well as to 5-HT-induced hyperalgesia in vivo (Aley and Levine, 1999). 
Whether enhanced TRPV1 or TTX-R Na+ currents are involved in 5-HT-induced OA, 
and the extent to which the mechanisms described in this study contribute to 
hyperalgesia in vivo, are not yet known. It is important to note that, while my measure 
of cAMP production in response to 5-HT and its analogs was type II PKA activity, this 
does not rule out the interesting possibility of significant contributions of type I PKAs to 
at least some of the 5-HT effects I observed. 
While a number of studies demonstrated a role for EPAC in neuropathic and 
inflammatory pain (Berkey et al., 2020; Huang and Gu, 2017; Z.-H. Li et al., 2019; 
Singhmar et al., 2018), the link between 5-HT signaling and EPAC activity in nociceptors 
had not been explored. I found that EPAC1 and 2 activity (primarily in combination) 
contributed significantly to the hyperexcitable state induced by 5-HT. The need to block 
both EPAC isoforms to significantly attenuate the effects of 5-HT in rat DRG neurons is 
in contrast to the observation that inhibition of either EPAC1 or EPAC2 was sufficient to 
reverse spinal cord injury-induced nociceptor hyperactivity (Berkey et al., 2020), 
suggesting differences in the role of EPAC in persistent spinal cord injury-induced OA 
and acute 5-HT potentiation of OA. 
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Lastly, I found statistically insignificant trends for reduced excitability when 
inhibiting HCN channels during 5-HT treatment, suggesting that (at most) HCN channels 
are a minor contributor to the 5-HT-induced effects I measured. This is consistent with 
the enhancement of DSFs and OA occurring primarily at relatively depolarized 
membrane potentials where few HCN channels should be active. Inhibiting any one of 
the cAMP effectors tested (PKA, EPAC1/2, and HCN) failed to prevent 5-HT’s reduction 
of rheobase (measured from a holding potential of -60 mV), suggesting that additive 
effects of these components of cAMP signaling, and perhaps other cell signaling 
pathways, drive this manifestation of 5-HT-induced hyperexcitability. 
The promotion of OA by the cAMP analog 8-Br-cAMP showed that activation of 
cAMP signaling is sufficient to reduce AP threshold and enhance DSFs to increase 
nociceptor excitability. This suggests that other mediators, such as PGE2, that activate 
Gs-coupled receptors on DRG neurons may enhance OA by similar mechanisms. While 
8-Br-cAMP depolarized RMP (to ~-57 mV), further depolarization (experimentally, to ~-
45 mV) was required to reveal effects on OA, as was also observed with 5-HT. Direct 
activation of adenylyl cyclase with forskolin produces effects similar to those of 8-Br-
cAMP delivery (A. Bavencoffe, E.T. Walters, and C.W. Dessauer, unpublished 
observations). The lack of a significant increase in OA at RMP induced by 8-Br-cAMP 
despite the cAMP analog depolarizing RMP, reducing AP threshold, and enhancing 
DSFs can be explained by its insufficient alteration of some or all of the 
electrophysiological components that drive OA. Specifically, the hyperpolarization of AP 
threshold and increased incidence of large DSFs induced by 8-Br-cAMP were modest 
compared to what was observed with 5-HT, and the depolarization of RMP by 8-Br-
cAMP to ~-57 mV is not close to the -45 mV holding potential used to enable OA during 
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5-HT treatment. The weaker effects of a relatively high concentration of 8-Br-cAMP 
compared to those of low doses of 5-HT are consistent with findings that OA generation 
in nociceptors involves interaction of cAMP signaling with at least one other signaling 
pathway. Interestingly, depolarization to -45 mV, where we see the marked effects on 
OA and DSFs with cAMP activation, also activates the extracellular signal-regulated 






Effects in the DRG of deep tissue incision in a rat 





 The studies described thus far have provided detailed insight into cell signaling 
mechanisms that promote OA, in part by enhancing the underlying DSFs. To gain further 
insight into the contribution of DSFs and OA to different types of pain and the relevance 
of the mechanisms uncovered in previous chapters, it is important to examine pain and 
OA in a model that mimics a pain condition seen in humans. One such model is the 
deep tissue plantar incision rat model of postsurgical pain (Brennan et al., 1995). With 
80% of surgical patients experiencing postoperative pain and 86% of these patients 
reporting the pain as moderate, severe, or extreme, it is clear that postsurgical pain is 
an important clinical problem for which new treatment options are needed (Apfelbaum 
et al., 2003; Gan et al., 2014; Gupta et al., 2010). It is estimated that 10-50% of surgical 
patients develop persistent pain that lasts for months, and 2-10% of patients describe 
this persistent postoperative pain as severe (Kehlet et al., 2006). There is evidence that 
more severe acute postsurgical pain increases the likelihood of developing chronic pain 
(Callesen et al., 1999; Katz et al., 1996; Perkins and Kehlet, 2000; Tasmuth et al., 1996). 
Thus, managing postsurgical pain early has the potential to prevent persistent 
postoperative pain.  
 In the common rat model of incisional pain (Brennan et al., 1995), a deep tissue 
incision (through skin, fascia, and muscle) on the plantar aspect of the hind paw induces 
pain and nociceptor ongoing activity (Xu and Brennan, 2010). Guarding behavior, a 
measure of non-evoked pain, and heat hyperalgesia were demonstrated to last up to 
five days post-incision in the incised paw (Xu and Brennan, 2010). Peripheral in vivo 
electrophysiological recordings showed ongoing activity in nociceptors one day post-
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incision that correlated with guarding pain behavior and was resolved by seven days 
post-incision (Xu and Brennan, 2010).  
 Changes in pro-inflammatory cytokines, growth factors, cell signaling, or ion 
channel activation have been identified that contribute to pain after plantar incision. For 
example, p38 MAPK phosphorylation increases in the DRG following deep tissue 
incision and contributes to peripheral nerve sensitization (Mizukoshi et al., 2013), and 
this was linked to macrophage accumulation and increased TNF-α in the incised plantar 
tissue (Yamakita et al., 2017). TNF- α is also increased in the DRG and spinal cord post-
incision (Chang et al., 2018), and phosphorylation of CREB, a transcription factor 
phosphorylated by PKA, is enhanced in the lumbar spinal cord following plantar incision 
(Cui et al., 2010). Upregulation of TRPV1 activity in nociceptor somata was linked to 
heat hypersensitivity after skin incision (Barabas and Stucky, 2013). A recent study 
examining the effects of sleep deprivation on post-surgical pain found no significant 
effect of incision alone on RMP or current threshold in large DRG neurons (which include 
relatively few nociceptors) 8-9 days post-incision (Q. Li et al., 2019). Electrophysiological 
changes that occur in nociceptor somata after deep tissue incision have not yet been 
defined. 
 While it is known that deep tissue plantar incision leads to OA in nociceptor 
peripheral fibers in vivo and changes in cell signaling pathways (e.g. p38 MAPK and 
ERK), inflammation (e.g. increased IL-1β, TNF-α, and IL-6) and ion channel regulation 
(e.g. TRPV1 activity) in the DRG, whether OA occurs in isolated nociceptor somata and 
what specific electrophysiological alterations contribute to OA after deep tissue plantar 




6.2.1. OA persists in isolated nociceptors after deep tissue incision 
 To determine whether OA persists in isolated nociceptors after deep tissue 
incision, how long it persists, and what neurophysiological alterations contribute, I used 
whole-cell patch clamp recording of dissociated DRG neurons. Neurons were 
dissociated from the L4-L6 DRG as these contain the somata of sensory neurons that 
innervate the incised area of the hind paw. Neurons were dissociated on postoperative 
days (POD) 1, 7, and 14, and ipsilateral and contralateral sides were kept separate. 
Based on the correlation between OA in isolated DRG neurons and OA and/or 
behavioral alterations in vivo in other pain models, as well as the brief time course of 
electrophysiological and behavioral alterations previously described for the incision 
model (lasting less than 1 week), I expected to observe OA in DRG neurons isolated 
from the side ipsilateral to the incision on POD1 but not on POD7. Surprisingly, the 
largest increase in OA at rest (often referred to as spontaneous activity) occurred in the 
probable nociceptors isolated from the ipsilateral side on POD7 (Figure 16A, C; Fisher’s 
exact test, p = 0.0012). Ongoing activity during artificial depolarization to -45 mV was 
significantly increased in ipsilateral neurons isolated on POD1 and POD7 compared to 
those isolated from naïve, uninjured rats (Figure 16C; Fisher’s exact test, p = 0.0031 







Deep tissue incision was associated with depolarization of the RMP (a 
hyperexcitable effect) in probable nociceptors isolated from the ipsilateral side on POD1, 
7, and 14 (Figure 16D; Kruskal-Wallis, p = 0.0443, p = 0.0234, and p = 0.0207, 
respectively). The AP threshold was significantly hyperpolarized in ipsilateral neurons 
isolated on POD1 and 7 (Figure 16E; one-way ANOVA, p = 0.0453 and p = 0.0106, 
respectively). The frequency of medium-amplitude (3-5 mV) DSFs measured during 
depolarization to -45 mV was markedly increased in ipsilateral DRG neurons isolated 
on POD7 (Figure 16F; Kruskal-Wallis, p = 0.0003). Interestingly, DRG neurons isolated 
from the contralateral side at this timepoint also exhibited a significantly increased 
frequency of medium-amplitude DSFs (Figure 16F; Kruskal-Wallis, p = 0.0142). There 
was no statistically significant effect on large-amplitude (> 5 mV) DSFs (Figure 16F; 
Kruskal-Wallis, p = 0.1234). Additionally, the rheobase was significantly reduced in 
ipsilateral DRG neurons isolated on POD7 (Figure 16B; Kruskal-Wallis, p = 0.0026). 
To determine whether this unexpected persistence of nociceptor hyperactivity 
was associated with more prolonged pain behavior than what has been shown 
Figure 16. Hyperactivity persists in isolated DRG neurons after deep tissue 
incision. (A) Representative traces of naive and post-incision (isolated on 
postoperative day 7) neurons at rest. (B) Effect of incision on the rheobase. Mean ± 
SEM. ** p < 0.01. (C) Effect of incision on the incidence of OA determined from ≥60-
s recordings at RMP then 30-s recordings at ~-45 mV. * p < 0.0083 ** p < 0.0017 
(Bonferroni corrections for 6 comparisons). (D) Effect of incision on RMP measured 
during ≥60-s recordings. Mean ± SEM. * p < 0.05. (E) Effect of incision on the AP 
voltage threshold. Mean ± SEM. * p < 0.05. (F) Effects of incision on the frequency of 
medium- (3-5 mV) and large-amplitude (> 5 mV) DSFs during 30-s depolarization to 
-45 mV. Mean ± SEM. * p < 0.05 *** p < 0.001. DSF data processed by Michael Zhu. 
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previously, I examined guarding behavior at 1, 7, and 14 days post-incision. A previous 
study (Xu and Brennan, 2010) correlated guarding behavior, a measure of non-evoked 
pain with in vivo spontaneous activity (equivalent to OA) in C-fiber nociceptors. They 
observed increased guarding behavior on POD1 but not on POD6 in rats with deep 
tissue incision, and guarding had resolved by POD1 in rats with incision through the skin 
only. Similarly, I found guarding behavior to be significantly increased on POD1 (Figure 
17; Kruskal-Wallis, p = 0.0035) but absent on POD7. The apparent increase in guarding 
behavior in sham incised rats on POD1 was not statistically significant (Figure 17; 
Kruskal-Wallis, p = 0.1851). This suggests that our deep tissue incision condition is 
comparable in the time course of non-evoked pain resolution to published studies.  
 
Figure 17. Guarding pain behavior is resolved by POD7. Guarding behavior 
measured during 12 one-minute observation periods every 3 or 4 minutes. Mean 
± SEM. 2-way ANOVA, F(11,49) = 13.56, p < 0.0001, followed by separate Kruskal-
Wallis tests for each time point, ** p < 0.01. POD, postoperative day; Deep, incision 
through skin, fascia, and muscle (deep tissue incision); Sham, incision through 
skin and possibly fascia but not muscle; Naïve, no incision. 
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6.2.2. Global transcriptome analysis of rat DRG to identify genes involved in 
persistent nociceptor hyperexcitability after deep tissue incision 
 The unexpected findings of hyperexcitability persisting in isolated nociceptors for 
at least 7 to 14 days post-incision (Figure 16D) and of hyperexcitable effects in DRG 
neurons contralateral to the incision (Figure 16F) raise many questions, including 
whether alterations in gene expression might underlie this persistent hyperexcitability. 
To address the question of whether gene expression changes accompany hyperactivity 
of DRG neurons at 7 days post-incision, the timepoint where the greatest effect on OA 
at RMP was observed (Figure 16C), I turned to the unbiased approach of RNA 
sequencing. To detect potential changes in gene expression bilaterally, RNA was 
extracted separately from ipsilateral L4-6 DRG and contralateral L4-6 DRG and similarly 
from left (corresponding to the ipsilateral side of incised rats) and right (corresponding 
to the contralateral side) L4-6 DRG from naïve rats. Therefore, ipsilateral and 
contralateral sides each had their own control in case lateralized differences occur 
normally. All samples had similar levels of gene expression (Figure 18A), and replicates 
correlated well with each other (Figure 18B). For differential gene expression, cutoffs 
were set at 2-fold change and p value < 0.01. 









In ipsilateral DRG, 6 genes, Vip, Fam131a, RragB, Stac2, Ecel1, and Yif1b were 
significantly upregulated compared with naïve controls, and 1 gene, Zfp622, was 
downregulated (Figure 19; Table 1). In contralateral DRG, only one gene was 
differentially expressed; AC115341.1 was downregulated compared to naïve controls 
(Figure 20; Table 2). The differentially expressed genes are discussed in section 6.3.  
  
Figure 18. Gene expression distribution and correlation between samples. (A) 
Box plots displaying the distribution of gene expression levels and FPKM among 
different samples. FPKM, number of fragments per kilobase length of gene per million 
fragments. (B) Correlation coefficient matrix. R2, square of Pearson correlation 
coefficient (R). INJ_CON, incised (injured) contralateral group; NV_CON, naïve 
contralateral group; INJ_IPS, incised ipsilateral group; NV_IPS, naïve ipsilateral 
group; IR, incised contralateral sample; NR, naïve contralateral sample; IL, incised 




Figure 19. Volcano plot of ipsilateral differentially expressed genes 7 days post-
incision. Expression in L4-6 DRG from the ipsilateral side of incised rats compared 
to L4-6 DRG from the same side of naïve rats. Points represent genes labeled with 















Vip Vasoactive intestinal peptide 4.8922 0.0000 1 
Zfp622 Zinc finger protein -3.9261 0.0000 2 
Fam131a 
Family w/ sequence similarity 131, 
member A 
2.6137 0.0003 11 
RragB Ras-related GTP binding B 2.4283 0.0004 X 
Stac2 SH3 & cysteine rich domain 2 1.8303 0.0015 10 
Ecel1 Endothelin converting enzyme-like 1 1.3285 0.0036 9 
Yif1b Yip1 interacting factor homolog B 3.8085 0.0081 1 
Table 1. Genes differentially expressed in ipsilateral DRG at 7 days post-





Figure 20. Volcano plot of contralateral differentially expressed genes 7 days 
post-incision. Expression in L4-6 DRG from the contralateral side of incised rats 
compared to L4-6 DRG from the same side of naïve rats. Points represent genes 
labeled with the gene name. Dashed lines represent cutoffs of 2-fold change and p < 
0.01.  
Table 2. Genes differentially expressed in contralateral DRG at 7 days post-
incision compared to naïve controls. 
 






phosphatase 2A activator 
-1.0558 0.0000 3 
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 To establish the noise threshold, I used an approach that takes into account 
sample-to-sample variation, as described recently by Koch, et al. (Koch et al., 2018). 
Variability between samples was visualized for this purpose by comparing the number 
of genes expressed at different cutoffs across all samples. The samples did not become 
indistinguishable until an FPKM cutoff of 0.5 was reached, permitting a low counts 
threshold of FPKM = 0.5 (Figure 21). All differentially expressed genes were above this 
determined noise level in at least 3 out of 4 replicates in at least one condition (incised 
or naïve) (Table 3).  
 
Figure 21. Quantification of genes with expression above different FPKM cutoff 
values. The gene expression distributions across different samples align quickly, 
leading to a threshold of FPKM = 0.5. IL, incised ipsilateral; NL, naïve ipsilateral; 1-4, 





 With the plantar incision model of post-surgical pain, I have shown thus far that 
deep tissue incision potentiates OA, depolarizes RMP, and hyperpolarizes AP threshold 
in DRG neurons isolated from the ipsilateral side 1 day post-incision. Unexpectedly, the 
largest changes in ipsilateral DRG neurons compared with naïve controls were observed 
in probable nociceptors isolated 7 days post-incision, with an increased incidence of OA 
at RMP and at -45 mV, depolarized RMP, hyperpolarized AP threshold, and enhanced 
DSFs. Depolarization of RMP was also present in DRG neurons isolated 14 days post-
incision. Additionally, enhanced DSFs were detected in DRG neurons isolated from the 
contralateral side 7 days post-incision. These results suggest that hyperexcitable effects 
of deep tissue incision on nociceptors persist longer than what has been revealed by in 
vivo behavioral tests and that some effects occur bilaterally. This persistent 
hyperexcitability observed in isolated nociceptors may be the result of a “primed” state 
induced by the incision that is revealed by the stress of the dissociation procedure. 
Alternatively, nociceptor hyperexcitability may be actively suppressed in vivo, such as 
by endogenous opioid pathways, and thus is only revealed when the nociceptors are 
Table 3. FPKM values of genes differentially expressed in ipsilateral and 
contralateral DRG at 7 days post-incision. IL, incised ipsilateral; NL, naïve 
ipsilateral; IR, incised contralateral; NR, naïve contralateral; 1-4, biological replicates.  
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removed from such suppressive mechanisms, which would be consistent with the recent 
finding that hyperalgesia can be reinstated by opioid receptor antagonists 21 days post-
incision (Custodio-Patsey et al., 2020). Hypotheses and future directions regarding the 
mechanisms underlying the hyperexcitability in isolated nociceptors lasting longer than 
in vivo pain will be discussed in Chapter 7. 
 In contrast to a recent study that found 126 genes differentially expressed in DRG 
1 day post-incision compared with controls (Tran et al., 2020), my RNA sequencing 
revealed few transcriptional changes in DRG 7 days post-incision compared to naïve 
controls, suggesting that alterations at the level of gene expression may not account for 
the observed effects on nociceptor excitability at this time point. Given the ability of 5-
HT to produce covert hyperexcitability (revealed only when membrane potential is 
depolarized) shown in Chapter 3, an important question was whether the mRNAs for 
any 5-HT receptors changed in expression after incision. Several 5-HT receptor mRNAs 
were present in my DRG samples– in descending order of abundance, Htr3b, Htr3a, 
Htr1d, Htr1b, Htr4, Htr1a, Htr2a, Htr5b, and Htr2c. However, there was no significant 
differential expression of any 5-HT receptors 7 days post-injury. The only differentially 
expressed genes identified are described briefly below. 
 Vip: The upregulated gene showing the most statistical significance (Figure 19, 
Table 1) on POD7 in ipsilateral DRG, albeit still at a low level of expression (Table 3), 
was Vip, which encodes vasoactive intestinal peptide (VIP). VIP is a neuropeptide that 
was originally reported as a vasodilator (Said and Mutt, 1970) and has since been found 
to have a wide array of physiological and pathological effects, including but not limited 
to gastrointestinal function and diseases (Iwasaki et al., 2019), cancer (Siddappa and 
Vege, 2019), and pain (Bourlev et al., 2018; McDougall et al., 2006). VIP carries out its 
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activities by binding the Gs-coupled receptors VPAC1/2 (Moody and Jensen, 2013) and 
is widely distributed in the CNS and PNS (Lorén et al., 1979; Said, 1984).  
 Fam131a: This gene encodes a FAM131 family member. Little is known about 
the function of these proteins other than their ability to be myristoylated (Suzuki et al., 
2010), suggesting a putative role in cell signaling.  
 RragB: RAS-related GTP-binding protein B (RRAGB), as the name suggests, is 
a GTPase that is homologous to RAS, a GTPase that is well-known for its role in cancer. 
GTPases are cellular switches that alternate between an active GTP-bound state and 
an inactive GDP-bound state. RRAG family GTPases are known to be involved in 
cellular responses to amino acid availability by regulating signaling through mammalian 
target of rapamycin complex 1 (mTORC1) (Takahara et al., 2020). The function of 
RRAGB in the DRG has not been studied. Interestingly, the activity of its homolog, RAS, 
appears to be involved in nociceptor hyperexcitability stimulated by membrane 
depolarization (Garza Carbajal et al., 2020). 
 Stac2: Another gene of interest that was significantly upregulated was Stac2, 
which encodes SH3 and cysteine-rich domain-containing protein 2 (STAC2). About a 
decade ago, STAC1 and STAC2, of unknown function at the time, were shown to be 
expressed in distinct subsets of DRG neurons (Legha et al., 2010). Since then, studies 
in neurons of the brain have uncovered a role for STAC2 in the regulation of voltage-
gated Ca2+ channel activity (Campiglio et al., 2018; Polster et al., 2018, 2015). 
 Ecel1: Endothelin converting enzyme like 1 (ECEL1), also known as 
damage-induced neuronal endopeptidase (DINE) is a neuron-specific membrane-bound 
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metalloprotease that shares homology with neprilysin and endothelin-converting 
enzyme, which degrade or process neuropeptides (Benoit et al., 2004; Kiryu-Seo et al., 
2000). Transcriptional responses of this gene have been observed with various types of 
nerve injuries (Kaneko et al., 2017; Kiryu-Seo, 2006). For example, Ecel1 expression 
was observed in small sized DRG neurons after sciatic nerve injury. The function and 
substrate(s) of ECEL1 are largely unknown, but some evidence suggests it has 
neuroprotective effects (Kaneko et al., 2017; Matsumoto et al., 2016).  
 Yif1b: YIP1 interacting factor homology B (YIF1B) is involved in anterograde 
trafficking from the endoplasmic reticulum to the plasma membrane and in the 
organization of Golgi architecture (Alterio et al., 2015; Matern et al., 2000). YIF1B plays 
a key role in targeting the 5-HT1A receptor to neuronal dendrites in the brain (Carrel et 
al., 2008). It is known that YIF1B does not interact with the 5-HT1B receptor (Carrel et 
al., 2008), but whether or not YIF1B has affinity for other 5-HT receptors, or receptors 
for other neuromodulators, and what its function is in the DRG are not known.  
 Zfp622: The only gene found to be downregulated in ipsilateral DRG 7 days post-
incision encodes zinc finger protein 622 (ZFP622), also known as zinc finger-like protein 
9 (ZPR9), which was originally identified as a substrate of murine protein 
serine/threonine kinase 38 (MPK38) (Seong et al., 2002). ZNF622 regulates apoptosis 
signal-regulating kinase 1 (ASK1), transforming growth factor β (TGF-β), and p53 
signaling pathways (Seong et al., 2017), and a recent study suggests ZFP622 may act 
as a cellular antiviral protein in humans (Mun and Punga, 2018). The function of ZFP622 
in the DRG has not been studied. 
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 AC115341.1: The only gene found to be differentially expressed in contralateral 
DRG 7 days post-incision was a pseudogene of Ptpa, a gene encoding a 
serine/threonine protein phosphatase 2A activator. PTPAs accelerate protein folding 
and catalyze cis-trans isomerization of proline imidic peptide bonds in oligopeptides 
(www.uniprot.org). 
It is important to note that differential expression studies were conducted from 
RNA extracted from whole DRG tissue, so while predictions can be made based on what 
is known about the expression of these genes, it is uncertain whether the genes of 
interest were expressed in nociceptors, other sensory neurons, or non-neuronal cell 
types. Furthermore, a relatively low expression in the whole DRG does not mean that a 
given gene could not be expressed to a much greater degree in a subpopulation of DRG 
neurons of a subset of nociceptors. Finally, increasing evidence indicates that 
translational modifications of DRG neurons are important for driving pain, perhaps even 
more important than transcriptional alterations (Megat et al., 2019). Predictions and 
future directions regarding the potential roles of the differentially expressed genes 









7.1. Summary of conclusions  
 The major findings of this study are (1) that low concentrations of 5-HT promote 
acute OA through the Gs-coupled 5-HT4 receptor and downstream cAMP signaling, 
predominantly via activation of PKA, with some contributions from EPAC (Figure 22), 
and (2) that OA persists in isolated nociceptors for weeks after deep tissue plantar 
incision, with effects on RMP, AP threshold, and DSFs but with few transcriptional 
changes associated with this persistent OA.  
7.2. Functional implications of 5-HT4-dependent cAMP signaling in 
nociceptors 
Nociceptor OA induced by injury or inflammation may be generated in peripheral 
terminals, axonal neuromas, and/or the soma, with each site potentially exposed 
persistently to inflammatory mediators, including 5-HT (discussed by Walters, 2019). 
Our findings set the stage for multidisciplinary approaches to define potentially important 
contributions of 5-HT-stimulated cAMP signaling in nociceptors – within the DRG and at 





 The nociceptor hyperexcitability mechanisms described in Chapters 3-5 may 
contribute to pain associated with peripheral tissue injury, such as incisional pain. As 
described in Chapter 1, 5-HT is one of several mediators released by activated mast 
cells. Mast cells release 5-HT when activated by injuries such as plantar incision 
(Oliveira et al., 2011). Serotonin-cAMP signaling promotes OA by reducing AP threshold 
and enhancing DSFs, with the OA generated in the periphery and/or soma likely to 
contribute to ongoing pain and central sensitization. The effects of 5-HT-cAMP signaling 
Figure 22. Graphical summary of 5-HT4-mediated potentiation of OA in 
nociceptors. In isolated nociceptors exposed to 5-HT for 5-60 min, the Gs-coupled 
5-HT4 receptor stimulates cAMP signaling, with the effectors PKA and EPAC causing 
hyperpolarized AP threshold and enhanced DSFs, thereby potentiating OA in the 
presence of a depolarizing stimulus. reprinted from E. R. Lopez, A. Garza Carbajal, 
J. B. Tian, A. Bavencoffe, M. X. Zhu, C. W. Dessauer, and E. T. Walters. 2021. 
Serotonin enhances depolarizing spontaneous fluctuations, excitability, and ongoing 
activity in isolated rat DRG neurons via 5-HT4 receptors and cAMP-dependent 
mechanisms. Neuropharmacology 184: 108408. Use of the text and figures are 




on rheobase may be particularly relevant in the periphery, where increased 5-HT4 
activity in nociceptors may render their peripheral terminals more sensitive to sensory 
generator potentials and thereby contribute to hyperalgesia. 
 As my studies were conducted in isolated DRG neurons, the mechanisms of 
nociceptor hyperexcitability defined by these studies may be especially relevant in the 
DRG. Besides mast cells, 5-HT is also stored in platelets and released upon platelet 
activation. Interestingly, 5-HT is elevated in the plasma as well as in the CSF acutely 
following spinal cord injury (Brodner et al., 1980; Sharma et al., 1993). A study also 
found significantly elevated plasma 5-HT levels in patients with primary fibromyalgia 
syndrome (PFS), a condition characterized by diffuse chronic pain, compared to controls 
(Legangneux et al., 2001). Because DRG are perfused by blood in addition to CSF 
(Abram et al., 2006; Godel et al., 2016), the contribution of circulating and intrathecal 5-
HT to the early C-fiber OA generated within the DRG in vivo after spinal cord injury (Bedi 
et al., 2010) or to PFS pain warrants further investigation.  
7.3. Advantages and potential pitfalls of a pharmacological approach 
to studying molecular mechanisms 
The necessity and relative contribution of a given pathway or protein to a 
physiological outcome of interest can be determined experimentally by examining the 
effects of functionally removing the pathway or protein. Functional removal can be 
achieved by genetic deletion or suppression or by pharmacological inhibition. 
Pharmacological approaches to studying molecular mechanisms include antibody-
based, peptide-based, and (most commonly) small-molecule based treatments to inhibit, 
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or in some cases activate, a protein of interest. Compared to genetic approaches, 
pharmacological inhibition typically takes place on a significantly shorter time scale. On 
the one hand, creating a knockout mouse when one is not already available can take 
about a year from start to finish (www.med.umich.edu/tamc), and effective knockdown 
of a gene may involve a slow turnover rate of already existing gene products. On the 
other hand, the effects of pharmacologically inhibiting a protein typically occur within 
seconds to hours, depending on the mode of delivery and the outcome being measured. 
Pharmacological tools also provide the power to observe the effects of inhibiting the 
target of interest in real time (avoiding compensatory effects that often occur with 
transgenic approaches) and the ability to compare functional outcomes before and after 
inhibition of the target within the same animal or the same cell. Pharmacological studies 
also provide an additional degree of translatability since, in many cases, it is more 
feasible to treat a human with a drug than to knock out or knock down a gene in a patient.  
Nonetheless, there are a number of major weaknesses to keep in mind when 
employing a pharmacological approach. Notably, it is common for drugs to exhibit 
significant off-target effects, especially in the case of kinase inhibitors (Davis et al., 2011; 
Michel and Seifert, 2015). Cell permeability is also a common issue for drugs with 
intracellular targets. Different drugs differ in their ability to cross the plasma membrane, 
and the extracellular concentration of drug is often a poor predictor of its intracellular 
concentration. Even if a drug is applied intracellularly, such as via a micropipette in an 
electrophysiological assay, it can be difficult to know the local concentration at the target. 
Thus, the effective concentration of a drug against its target as determined in a cell-free 
assay, may have limited translation to a cell, tissue, or intact animal. This could lead to 
under-dosing and result in false negative data. However, higher doses are more likely 
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to lead to off-target effects that may result in false positive data. Additionally, known off-
target effects are often overlooked. Furthermore, high doses of some drugs may lead to 
negative effects of the drug or its solvent on membrane properties or cell integrity, 
complicating the interpretation of effects in intact cells, and some compounds may 
interfere with the assay itself rather than the pathway under study, making the results 
uninterpretable. 
I have attempted to minimize these pitfalls by reviewing the primary literature on 
the use of each drug, as information provided by a supplier may be biased. Instead of 
relying on doses reported in other studies, for the most important drugs, I determined 
dose-response relationships before choosing my experimental drug concentration. To 
control for solvent effects, vehicle controls were used where appropriate. Furthermore, 
I substantiated the role of PKA by including two structurally distinct drugs that work by 
different modes of action.  
7.4. Future directions 
While I was able to define a 5-HT-dependent mechanism that potentiates OA in 
nociceptors as well as uncover an unexpected time course of OA in DRG neurons 
isolated after plantar incision, there are many questions left to explore. Future directions 
of greatest interest are discussed below. 
7.4.1. cAMP signaling in nociceptors – what about POPDC? 
 POPDC is the most recently discovered cAMP effector. The Popdc gene family 
consists of Popdc 1, Popdc2, and Popdc3. My RNA sequencing data indicates that 
Popdc3 and Popdc2 are expressed in rat DRG, and previous studies showed expression 
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of Popdc1 in the DRG and neurons of the spinal cord in embryonic mice (Andrée et al., 
2002a, 2002b). Major advances in understanding POPDC function thus far established 
its important role in regulating heart rate and skeletal muscle regeneration. Importantly, 
POPDCs are known to interact with ion channels (Schindler and Brand, 2016). For 
example, in the heart, cAMP modulates the direct interaction of POPDC with the two-
pore K+ channel TREK-1; binding of cAMP to POPDC disrupts its interaction with TREK-
1, thereby reducing the plasma membrane localization of TREK-1 and impacting heart 
rate dynamics (Froese et al., 2012). The potential role of POPDC in neurons remains to 
be explored and will be an important avenue for future research to further our 
understanding of cAMP signaling in the peripheral nervous system and whether cAMP-
POPDC signaling plays a role in ion channel regulation in sensory neurons. 
7.4.2. Role of 5-HT/cAMP signaling in postsurgical pain 
 A study by Oliveira and colleagues demonstrated that 5-HT levels increased in 
the paw after plantar incision in mice, and reduction of 5-HT levels in the paw by mast 
cell depletion was associated with decreased mechanical allodynia post-incision 
(Oliveira et al., 2011). Oliveira et al. (2011) found that pretreatment with selective 5-HT3 
or 5-HT2A receptor antagonists partially attenuated mechanical allodynia 0.5, 1, and 2 
hours after incision, and they were able to achieve complete reversal of mechanical 
allodynia by coadministration of 5-HT3 and 5-HT2A antagonists along with a histamine 
(another mast cell mediator) receptor antagonist. However, this study did not exclude 
potential roles for 5-HT4 receptors in other painful effects of incision, notably 
hyperalgesia and spontaneous pain, which were not examined. Hyperexcitability and 
OA in nociceptors are implicated in hyperalgesia and spontaneous pain, whereas 
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mechanical allodynia is thought to be expressed by the activation of A-fiber LTMRs (C. 
N. Liu et al., 2000; C.-N. Liu et al., 2000; Walters, 2021), which are likely excluded from 
our electrophysiological studies due to their larger size. Thermal hyperalgesia and 
spontaneous guarding pain behavior occur after plantar incision, so future studies 
should examine the contribution of mast cells, 5-HT, and 5-HT4 receptors to these types 
of post-incisional pain that are likely driven by hyperexcitability and OA in C-fibers 
(Djouhri et al., 2006; Wu et al., 2002; Xu and Brennan, 2010). Furthermore, Oliveira and 
colleagues (2011) showed 5-HT was increased in the paw within one hour post-incision, 
and levels dropped back down by 48 hours compared to sham-operated animals, but it 
is not clear how the 5-HT level at 48 hours compares to baseline/naive levels. It will be 
of interest in future studies to determine whether changes in 5-HT levels only occur 
locally or if increases can be detected in the blood or CSF as well as how long 5-HT 
levels remain elevated post-incision compared to baseline. 
7.4.3. Why does hyperactivity persist in isolated nociceptors longer than in vivo 
pain and OA? 
Studying longer-lasting effects of incision could provide clues to what is involved 
in the transition from acute to chronic postsurgical pain. One attractive hypothesis that 
could explain the hyperexcitability observed in isolated nociceptors at 7 and 14 days 
post-incision when pain behavior is no longer present is that it is a manifestation of 
hyperalgesic priming. Hyperalgesic priming is a model of pain plasticity in which an initial 
priming stimulus that sensitizes nociceptors, such as acute tissue damage or 
inflammation, leads to a primed state after the initial sensitization has apparently 
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resolved, resulting in an exaggerated nociceptive response to subsequent exposure to 
an inflammatory test stimulus (Kandasamy and Price, 2015; Price and Inyang, 2015). 
Plantar incision has been shown to act as a priming stimulus, resulting in 
exaggerated allodynia in response to a test intraplantar injection of PGE2 on 
postoperative day 14 (Baptista-de-Souza et al., 2020; Burton et al., 2017; Tillu et al., 
2012). While a modest dose of an inflammatory mediator such a PGE2 is typically used 
experimentally to precipitate primed behavioral responses long after the priming event 
(e.g. Burton et al., 2017; Khomula et al., 2017; Wang et al., 2018), it is conceivable that 
the DRG neuron isolation procedure, which involves severing the axons from the cell 
bodies in the process of DRG removal followed by chemical and physical disruption to 
dissociate the cells, could also precipitate primed responses, revealing a primed state 
induced by the incision that is manifested as nociceptor hyperexcitability. This 
hypothesis can be tested by seeing whether inhibitors of key players known to mediate 
hyperalgesic priming, such as PKCε (Aley et al., 2000) attenuate signs of 
hyperexcitability at 7 or 14 days post-incision.  
A related hypothesis involves the role of endogenous opioid receptor analgesia 
that suppresses latent pain sensitization and promotes the return to normal pain 
thresholds following tissue injury (Campillo et al., 2011; Corder et al., 2013). Inhibition 
of spinal µ- or κ-opioid receptors (MOR and KOR, respectively) reinstates mechanical 
allodynia 21 days after plantar incision (Custodio-Patsey et al., 2020). One way to relate 
the role of endogenous opioids to suppression of nociceptor OA is to test whether MOR 




7.4.4. Potential new molecular contributors to postsurgical pain suggested by 
transcriptional analysis 
Of the eight genes I found to be differentially expressed in DRG one week after 
plantar incision compared to naïve controls, two with functions that plausibly could 
contribute to nociceptor OA and postsurgical pain are discussed below. 
Vip: Vasoactive intestinal peptide (VIP) is a neuropeptide that activates Gs-
coupled VPAC receptors and is known to be present in subpopulations of trigeminal 
ganglion and DRG neurons (Kummer and Heym, 1986; Lazarov, 1994; Xie et al., 2020). 
Besides neurons, VIP is produced by other cell types, notably immune cells such as 
mast cells, T cells, and macrophages (Cutz et al., 1978; Delgado and Ganea, 2001; 
Leceta et al., 1994; Metwali et al., 2002; Wershil et al., 1993). Moreover, macrophages 
are present in DRG and have been shown to contribute to the initiation and maintenance 
of pain after spared nerve injury in mice (Yu et al., 2020). However, preliminary data 
revealed no significant activation of PKA by VIP in primary DRG neurons from naïve rats 
(A. Garza Carbajal, unpublished observations), suggesting that these cells may exhibit 
little to no response to this neuropeptide under normal conditions. Rather, the sensory 
neurons may be producing VIP for release at central terminals, which is in line with early 
studies showing that VIP is present in Lissauer’s tract and Lamina I of the dorsal horn 
of the spinal cord, where the central axons of nociceptors reach the spinal cord (Purves 
et al., 2001), in humans, cats, and rats (Anand et al., 1983; Basbaum and Glazer, 1983). 
Basbaum and Glazer (1983) noted that the staining pattern of VIP was indicative of 
secretion from Aδ-nociceptors, which represent an important but very small fraction of 
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DRG neurons. A later study demonstrated increased cAMP levels in the spinal cord 
linked to release of VIP from primary afferents (Liu and Gintzler, 2003). 
In addition to producing VIP, immune cells can also respond to VIP. Accordingly, 
VIP has also been implicated in neurogenic inflammation, whereby primary afferents 
release pro-inflammatory neuropeptides into tissues, initiating an inflammatory reaction 
which can in turn produce painful symptoms. For example, VIP is one of several 
neuropeptides implicated in neurogenic inflammation that induces psoriasis flares 
(Al’Abadie et al., 1995; Chan et al., 1997; Kwon et al., 2018; Naukkarinen et al., 1993), 
which has been linked to VIP’s ability to activate immune cells, such as mast cells, to 
release pro-inflammatory mediators (Choi and Di Nardo, 2018; Lowman et al., 1988; 
Scholzen et al., 1998). Interestingly, there is evidence that VIP and other neuropeptides 
can also have anti-inflammatory effects on immune cells. For example, VIP is able to 
inhibit macrophage production of pro-inflammatory cytokines such as TNF-α and IL-6 
(Delgado et al., 2003; Martínez et al., 1998). Such opposing activities may depend upon 
the physiological context (Baral et al., 2019).  
Increased VIP production by DRG neurons after plantar incision should be 
confirmed, such as by immunostaining or quantitative PCR. To rule out potential effects 
on DRG neurons of secretion of VIP from other cell types (e.g. macrophages) or possible 
interaction between DRG neurons via VIP secretion, a simple experiment would be to 
apply a VPAC receptor antagonist to DRG neurons isolated after incision to see if 
hyperactivity is attenuated. The contribution of VIP secretion from sensory neurons to 
post-incisional pain, either at the spinal cord or in peripheral tissue, can be tested by 
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intrathecal or intraplantar injection, respectively, of a VPAC receptor antagonist prior to 
behavioral tests.  
Stac2: An early study found that genes for Src homology 3 and cysteine rich 
domain proteins (STAC1 and STAC2) are expressed in a mutually exclusive fashion in 
mouse DRG neurons, with STAC1 predominantly expressed in peptidergic nociceptors 
and STAC2 expressed in a subset of nonpeptidergic nociceptors and low threshold 
mechanoreceptors (Legha et al., 2010). Under the assumption that this expression 
pattern is similar in rat DRG neurons, we can predict the Stac2 expression detected in 
my RNA sequencing study of whole DRG tissue occurred in a subset of nociceptors. 
STAC2 has been shown to inhibit Ca2+-dependent inactivation of neuronal L-type 
Ca2+ channels, thereby increasing these voltage-dependent Ca2+ currents (Polster et 
al., 2018). While the neuronal function of STAC2 has only been reported in the brain 
(Polster et al., 2018, 2015), we can predict based on these findings that STAC2 similarly 
increases L-type Ca2+ currents in nociceptors. Unpublished data implicates L-type Ca2+ 
channels in increased ERK signaling in rat DRG neurons after spinal cord injury (A. 
Garza Carbajal, unpublished observations), which has been linked to persistent 
nociceptor hyperactivity (Garza Carbajal et al., 2020), and Stac2 transcripts also appear 
to be upregulated after spinal cord injury (R. Cuevas-Diaz Duran, A. Garza Carbajal, Y. 
Li, E. T. Walters, C. W. Dessauer, and J. Wu, unpublished observations). Additionally, 
a recent study demonstrated L-type Ca2+ channel expression and activity in the DRG 
contributes to the effects of sleep deprivation on delayed recovery from postsurgical 
mechanical allodynia and heat hyperalgesia in rats (Li et al., 2019). Thus, an exciting 
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future direction is to investigate whether modulation of L-type Ca2+ channel activity by 
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